1
|
Fayand A, Hentgen V, Posseme C, Lacout C, Picard C, Moguelet P, Cescato M, Sbeih N, Moreau TRJ, Zhu YYJ, Charuel JL, Corneau A, Deibener-Kaminsky J, Dupuy S, Fusaro M, Hoareau B, Hovnanian A, Langlois V, Le Corre L, Maciel TT, Miskinyte S, Miyara M, Moulinet T, Perret M, Schuhmacher MH, Rignault-Bricard R, Viel S, Vinit A, Soria A, Duffy D, Launay JM, Callebert J, Herbeuval JP, Rodero MP, Georgin-Lavialle S. Successful treatment of JAK1-associated inflammatory disease. J Allergy Clin Immunol 2023; 152:972-983. [PMID: 37343845 DOI: 10.1016/j.jaci.2023.06.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2022] [Revised: 06/02/2023] [Accepted: 06/13/2023] [Indexed: 06/23/2023]
Abstract
BACKGROUND Gain-of-function variants of JAK1 drive a rare immune dysregulation syndrome associated with atopic dermatitis, allergy, and eosinophilia. OBJECTIVES This study sought to describe the clinical and immunological characteristics associated with a new gain-of-function variant of JAK1 and report the therapeutic efficacy of Janus kinase (JAK) inhibition. METHODS The investigators identified a family affected by JAK1-associated autoinflammatory disease and performed clinical assessment and immunological monitoring on 9 patients. JAK1 signaling was studied by flow and mass cytometry in patients' cells at basal state or after immune stimulation. A molecular disease signature in the blood was studied at the transcriptomic level. Patients were treated with 1 of 2 JAK inhibitors: either baricitinib or upadacitinib. Clinical, cellular, and molecular response were evaluated over a 2-year period. RESULTS Affected individuals displayed a syndromic disease with prominent allergy including atopic dermatitis, ichthyosis, arthralgia, chronic diarrhea, disseminated calcifying fibrous tumors, and elevated whole blood histamine levels. A variant of JAK1 localized in the pseudokinase domain was identified in all 9 affected, tested patients. Hyper-phosphorylation of STAT3 was found in 5 of 6 patients tested. Treatment of patients' cells with baricitinib controlled most of the atypical hyper-phosphorylation of STAT3. Administration of baricitinib to patients led to rapid improvement of the disease in all adults and was associated with reduction of systemic inflammation. CONCLUSIONS Patients with this new JAK1 gain-of-function pathogenic variant displayed very high levels of blood histamine and showed a variable combination of atopy with articular and gastrointestinal manifestations as well as calcifying fibrous tumors. The disease, which appears to be linked to STAT3 hyperactivation, was well controlled under treatment by JAK inhibitors in adult patients.
Collapse
Affiliation(s)
- Antoine Fayand
- Laboratoire de Chimie et de Biochimie Pharmacologiques et Toxicologiques, Centre National de la Recherche Scientifique (CNRS), Paris, France; Department of Internal Medicine, Tenon Hospital, Assistance Publique-Hôpitaux de Paris (APHP), Sorbonne Université, Paris, France
| | - Véronique Hentgen
- Pediatric Infectious Disease Group, Créteil, France; Department General Pediatrics, Centre Hospitalier de Versailles, Le Chesnay, France
| | - Céline Posseme
- Translational Immunology Unit, Institut Pasteur, Université de Paris Cité, Paris, France
| | - Carole Lacout
- Genetic Laboratory, Trousseau Hospital, Assistance Publique-Hôpitaux de Paris (APHP), Sorbonne Université, Paris, France; Department of Internal Medicine, Tenon Hospital, Assistance Publique-Hôpitaux de Paris (APHP), Sorbonne Université, Paris, France
| | - Capucine Picard
- Study Center for Primary Immunodeficiencies, Necker Hospital for Sick Children, Assistance Publique-Hôpitaux de Paris (APHP), Université de Paris Cité, Paris, France
| | - Philippe Moguelet
- Department of Pathology, Sorbonne Université, Tenon Hospital, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France
| | - Margaux Cescato
- Laboratoire de Chimie et de Biochimie Pharmacologiques et Toxicologiques, Centre National de la Recherche Scientifique (CNRS), Paris, France
| | - Nabiha Sbeih
- Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications, Université de Paris Cité, Paris, France
| | - Thomas R J Moreau
- Laboratoire de Chimie et de Biochimie Pharmacologiques et Toxicologiques, Centre National de la Recherche Scientifique (CNRS), Paris, France
| | - Yixiang Y J Zhu
- Laboratoire de Chimie et de Biochimie Pharmacologiques et Toxicologiques, Centre National de la Recherche Scientifique (CNRS), Paris, France
| | - Jean-Luc Charuel
- Département of Immunology, Groupement Hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France
| | - Aurélien Corneau
- Production et Analyse de données en Sciences de la vie et en Santé (PASS), Plateforme de Cytométrie de la Pitié-Salpêtrière, Unité Mixte de Service (UMS) 037, Sorbonne Université, Paris, France
| | - Joelle Deibener-Kaminsky
- Department of Internal Medicine and Clinical Immunology, Nancy University Hospital, University of Lorraine, Nancy, France; Molecular Engineering and Articular Physiopathology, Unité Mixte de Recherche 7365, Centre national de la recherche scientifique (CNRS), University of Lorraine, Nancy, France
| | - Stéphanie Dupuy
- BioMedTech Facilities, Institut national de la santé et de la recherche médicale (INSERM) Unité mixte de services (US) 36, Centre national de la recherche scientifique (CNRS) Unité d'appui et de recherche (UAR) 2009, Université de Paris Cité, Paris, France
| | - Mathieu Fusaro
- Study Center for Primary Immunodeficiencies, Necker Hospital for Sick Children, Assistance Publique-Hôpitaux de Paris (APHP), Université de Paris Cité, Paris, France
| | - Benedicte Hoareau
- Production et Analyse de données en Sciences de la vie et en Santé (PASS), Plateforme de Cytométrie de la Pitié-Salpêtrière, Unité Mixte de Service (UMS) 037, Sorbonne Université, Paris, France
| | - Alain Hovnanian
- Laboratory of Genetic Skin Diseases, Institut National de la Santé et de la Recherche Médicale (INSERM) U1163, Imagine Institute, Université de Paris Cité, Paris, France; Department of Genomics Medicine of Rare Diseases, Hôpital Necker Enfants Malades, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France
| | - Vincent Langlois
- Department of Internal Medicine, Jacques Monod Hospital, Le Havre, France
| | - Laurent Le Corre
- Macromolecular Modeling Platform, Laboratoire de Chimie et Biochimie, Pharmacologiques et Toxicologiques, Centre national de la recherche scientifique (CNRS), Unité Mixte de Recherche (UMR) 8601, Université de Paris Cité, Paris, France
| | - Thiago T Maciel
- Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications, Université de Paris Cité, Paris, France
| | - Snaigune Miskinyte
- Laboratory of Genetic Skin Diseases, Institut National de la Santé et de la Recherche Médicale (INSERM) U1163, Imagine Institute, Université de Paris Cité, Paris, France
| | - Makoto Miyara
- Département of Immunology, Groupement Hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France; Centre d'Immunologie et des Maladies Infectieuses, Institut national de la santé et de la recherche médicale (INSERM) U1135, Hôpital Pitié-Salpêtrière AP-HP, Sorbonne Université, Paris, France
| | - Thomas Moulinet
- Department of Internal Medicine and Clinical Immunology, Nancy University Hospital, University of Lorraine, Nancy, France; Molecular Engineering and Articular Physiopathology, Unité Mixte de Recherche 7365, Centre national de la recherche scientifique (CNRS), University of Lorraine, Nancy, France
| | - Magali Perret
- Immunology Laboratory, Lyon Sud Hospital, Hospices Civils de Lyon, University of Claude Bernard-Lyon 1, Lyon, France
| | | | - Rachel Rignault-Bricard
- Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications, Université de Paris Cité, Paris, France
| | - Sébastien Viel
- Department of Genomics Medicine of Rare Diseases, Hôpital Necker Enfants Malades, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France
| | - Angélique Vinit
- Production et Analyse de données en Sciences de la vie et en Santé (PASS), Plateforme de Cytométrie de la Pitié-Salpêtrière, Unité Mixte de Service (UMS) 037, Sorbonne Université, Paris, France
| | - Angèle Soria
- Dermatology-Allergology Department, Sorbonne Université, Tenon Hospital, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France
| | - Darragh Duffy
- Translational Immunology Unit, Institut Pasteur, Université de Paris Cité, Paris, France
| | - Jean-Marie Launay
- Service of Biochemistry and Molecular Biology, Institut national de la santé et de la recherche médicale (INSERM) U942, Hospital Lariboisière, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France
| | - Jacques Callebert
- Service of Biochemistry and Molecular Biology, Institut national de la santé et de la recherche médicale (INSERM) U942, Hospital Lariboisière, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France
| | - Jean Philippe Herbeuval
- Laboratoire de Chimie et de Biochimie Pharmacologiques et Toxicologiques, Centre National de la Recherche Scientifique (CNRS), Paris, France
| | - Mathieu P Rodero
- Laboratoire de Chimie et de Biochimie Pharmacologiques et Toxicologiques, Centre National de la Recherche Scientifique (CNRS), Paris, France
| | - Sophie Georgin-Lavialle
- Department of Internal Medicine, Tenon Hospital, Assistance Publique-Hôpitaux de Paris (APHP), Sorbonne Université, Paris, France.
| |
Collapse
|
2
|
Colboc H, Moguelet P, Bazin D, Letavernier E, Sun C, Chessel A, Carvalho P, Lok C, Dillies AS, Chaby G, Maillard H, Kottler D, Goujon E, Jurus C, Panaye M, Tang E, Courville P, Boury A, Monfort JB, Chasset F, Senet P, Schanne-Klein MC. Elastic fiber alterations and calcifications in calcific uremic arteriolopathy. Sci Rep 2023; 13:15519. [PMID: 37726292 PMCID: PMC10509184 DOI: 10.1038/s41598-023-42492-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2023] [Accepted: 09/11/2023] [Indexed: 09/21/2023] Open
Abstract
Calcific uremic arteriolopathy (CUA) is a severely morbid disease, affecting mostly dialyzed end-stage renal disease (ESRD) patients, associated with calcium deposits in the skin. Calcifications have been identified in ESRD patients without CUA, indicating that their presence is not specific to the disease. The objective of this retrospective multicenter study was to compare elastic fiber structure and skin calcifications in ESRD patients with CUA to those without CUA using innovative structural techniques. Fourteen ESRD patients with CUA were compared to 12 ESRD patients without CUA. Analyses of elastic fiber structure and skin calcifications using multiphoton microscopy followed by machine-learning analysis and field-emission scanning electron microscopy coupled with energy dispersive X-ray were performed. Elastic fibers specifically appeared fragmented in CUA. Quantitative analyses of multiphoton images showed that they were significantly straighter in ESRD patients with CUA than without CUA. Interstitial and vascular calcifications were observed in both groups of ESRD patients, but vascular calcifications specifically appeared massive and circumferential in CUA. Unlike interstitial calcifications, massive circumferential vascular calcifications and elastic fibers straightening appeared specific to CUA. The origins of such specific elastic fiber's alteration are still to be explored and may involve relationships with ischemic vascular or inflammatory processes.
Collapse
Affiliation(s)
- Hester Colboc
- Sorbonne Université, Hôpital Rothschild, Service Plaies et Cicatrisation, UMRS_1155, 5, Rue Santerre, 75012, Paris, France.
| | - Philippe Moguelet
- Sorbonne Université, Hôpital Tenon, Anatomie et Cytologie Pathologiques, Paris, France
| | - Dominique Bazin
- Université Paris-Saclay, CNRS, Institut de Chimie Physique, 91405, Orsay, France
| | - Emmanuel Letavernier
- Sorbonne Université, Hôpital Tenon, Service des Explorations Fonctionnelles Multidisciplinaires, UMRS_1155, Paris, France
| | - Chenyu Sun
- Laboratoire d'Optique et Biosciences, CNRS, Inserm, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France
| | - Anatole Chessel
- Laboratoire d'Optique et Biosciences, CNRS, Inserm, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France
| | - Priscille Carvalho
- Centre Hospitalier Universitaire de Rouen, Service de Dermatologie, Rouen, France
| | - Catherine Lok
- Centre Hospitalier Universitaire d'Amiens, Service de Dermatologie, Amiens, France
| | | | - Guillaume Chaby
- Centre Hospitalier Universitaire d'Amiens, Service de Dermatologie, Amiens, France
| | - Hervé Maillard
- Centre Hospitalier du Mans, Service de Dermatologie, Le Mans, France
| | - Diane Kottler
- Centre Hospitalier Universitaire de Caen, Service de Dermatologie, Caen, France
| | - Elisa Goujon
- Centre Hospitalier de Chalon-sur-Saône, Service de Dermatologie, Chalon, France
| | - Christine Jurus
- Clinique du Tonkin, Service de Médecine Vasculaire, Villeurbanne, France
| | - Marine Panaye
- Clinique du Tonkin, Service de Médecine Vasculaire, Villeurbanne, France
| | - Ellie Tang
- Sorbonne Université, Hôpital Tenon, Service des Explorations Fonctionnelles Multidisciplinaires, UMRS_1155, Paris, France
| | - Philippe Courville
- Centre Hospitalier Universitaire de Rouen, Anatomie et Cytologie Pathologiques, Rouen, France
| | - Antoine Boury
- Université Paris-Saclay, CNRS, Institut de Chimie Physique, 91405, Orsay, France
| | - Jean-Benoit Monfort
- Sorbonne Université, Faculté de Médecine, Service de Dermatologie et Allergologie, Hôpital Tenon, Paris, France
| | - François Chasset
- Sorbonne Université, Faculté de Médecine, Service de Dermatologie 3t Allergologie, Hôpital Tenon, INSERM U1135, CIMI, Paris, France
| | - Patricia Senet
- Sorbonne Université, Faculté de Médecine, Service de Dermatologie et Allergologie, Hôpital Tenon, Paris, France
| | - Marie-Claire Schanne-Klein
- Laboratoire d'Optique et Biosciences, CNRS, Inserm, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France
| |
Collapse
|
3
|
Soria A, Amsler E, Garel B, Moguelet P, Tieulié N, Cordoliani F, Guichard I, Mahé A, Grateau G, Boursier G, Georgin-Lavialle S. Systemic inflammatory trunk recurrent acute macular eruption (SITRAME): A new auto-inflammatory syndrome in adult? J Eur Acad Dermatol Venereol 2023; 37:e538-e542. [PMID: 36426626 DOI: 10.1111/jdv.18771] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/23/2022] [Accepted: 11/21/2022] [Indexed: 11/27/2022]
Affiliation(s)
- Angèle Soria
- Sorbonne Université, Service de Dermatologie et d'Allergologie, Hôpital Tenon, DMU3ID, APHP, Paris, France.,Centre d'Immunologie et des Maladies Infectieuses - Paris (Cimi-Paris), INSERM U1135, Paris, France
| | - Emmanuelle Amsler
- Sorbonne Université, Service de Dermatologie et d'Allergologie, Hôpital Tenon, DMU3ID, APHP, Paris, France
| | - Bethsabée Garel
- Sorbonne Université, Service de Dermatologie et d'Allergologie, Hôpital Tenon, DMU3ID, APHP, Paris, France
| | | | - Nathalie Tieulié
- Service de Rhumatologie, CHU Nice, Hôpital Pasteur, Nice, France
| | | | | | - Antoine Mahé
- Service de Dermatologie, Hôpital de Colmar, Colmar, France
| | - Gilles Grateau
- Sorbonne Université, Service de médecine interne, Hôpital Tenon, DMU 3ID, APHP, Paris, France.,Centre National de Référence des Maladies Auto-Inflammatoires et des Amyloses D'Origine Inflammatoire (CEREMAIA), Paris, France
| | - Guilaine Boursier
- Centre National de Référence des Maladies Auto-Inflammatoires et des Amyloses D'Origine Inflammatoire (CEREMAIA), Montpellier, France.,Laboratoire de Génétique des Maladies rares et autoinflammatoires, Service de Génétique moléculaire et cytogénomique, CHU Montpellier, Univ Montpellier, Montpellier, France
| | - Sophie Georgin-Lavialle
- Sorbonne Université, Service de médecine interne, Hôpital Tenon, DMU 3ID, APHP, Paris, France.,Centre National de Référence des Maladies Auto-Inflammatoires et des Amyloses D'Origine Inflammatoire (CEREMAIA), Paris, France.,INSERM U938, CRSA, Paris, France
| |
Collapse
|
4
|
Zakine È, Papageorgiou L, Bourguiba R, Mekinian A, Terrier B, Kosmider O, Hirsch P, Jachiet M, Audia S, Ardois S, Adélaïde L, Bigot A, Duriez P, Emile JF, Lazaro E, Fayard D, Galland J, Hié M, Humbert S, Jean A, Kostine M, Lacombe V, Le Guenno G, Lobbes H, Magy-Bertrand N, Marianetti-Guingel P, Mathian A, Outh R, Saillard C, Samson M, Vial G, Bouaziz JD, Moguelet P, Chasset F. Clinical and pathological features of cutaneous manifestations in VEXAS syndrome: A multicenter retrospective study of 59 cases. J Am Acad Dermatol 2023; 88:917-920. [PMID: 36343774 DOI: 10.1016/j.jaad.2022.10.052] [Citation(s) in RCA: 14] [Impact Index Per Article: 14.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2022] [Revised: 08/05/2022] [Accepted: 10/27/2022] [Indexed: 11/06/2022]
Affiliation(s)
- Ève Zakine
- Dermatology Department, Paris University, Faculty of Medicine, AP-HP, Saint Louis University Hospital, Paris, France
| | - Loula Papageorgiou
- Hematology and Cytology Department, Sorbonne University, INSERM, Saint Antoine Research Center, AP-HP, Saint Antoine University Hospital, Paris, France
| | - Rim Bourguiba
- Internal Medicine Department, Sorbonne University, Faculty of Medicine, AP-HP, Tenon University Hospital, Paris, France
| | - Arsène Mekinian
- Internal Medicine Department, Sorbonne University, Faculty of Medicine, AP-HP, Saint Antoine University Hospital, Paris, France
| | - Benjamin Terrier
- Internal Medicine Department, Paris University, Faculty of Medicine, AP-HP, Cochin University Hospital, Paris, France
| | - Olivier Kosmider
- Hematology Department, Paris University, Faculty of Medicine, AP-HP, Cochin University Hospital, Paris, France
| | - Pierre Hirsch
- Hematology and Cytology Department, Sorbonne University, INSERM, Saint Antoine Research Center, AP-HP, Saint Antoine University Hospital, Paris, France
| | - Marie Jachiet
- Dermatology Department, Paris University, Faculty of Medicine, AP-HP, Saint Louis University Hospital, Paris, France
| | - Sylvain Audia
- Internal Medicine Department, Bourgogne University, Faculty of Medicine, Dijon University Hospital, Dijon, France
| | - Samuel Ardois
- Internal Medicine Department, Rennes University, Faculty of Medicine, Rennes University Hospital, Rennes, France
| | - Léopold Adélaïde
- Internal Medicine Department, Claude Bernard Lyon 1 University, Faculty of Medicine, Croix-Rousse Hospital, Lyon, France
| | - Adrien Bigot
- Internal Medicine Department, Tours University, Faculty of Medicine, Tours University Hospital, Tours, France
| | - Paul Duriez
- Pathology Department, Sorbonne University, Faculty of Medicine, AP-HP, Saint Antoine University Hospital, Paris, France
| | - Jean-François Emile
- Pathology Department, Versailles Saint Quentin University, Faculty of Medicine, Ambroise Paré Hospital, Boulogne-Billancourt, France
| | - Estibaliz Lazaro
- Internal Medicine Department, Bordeaux University, Faculty of Medicine, Bordeaux University Hospital, Bordeaux, France
| | - Damien Fayard
- Internal Medicine Department, Clermont-Ferrand University, Faculty of Medicine, Gabriel Montpied University Hospital, Clermont-Ferrand, France
| | - Joris Galland
- Internal Medicine Department, Fleyriat Hospital, Bourg-en-Bresse, France
| | - Miguel Hié
- Internal Medicine Department, Sorbonne University, Faculty of Medicine, AP-HP, Pitié-Salpêtrière University Hospital, Paris, France
| | - Sébastien Humbert
- Internal Medicine Department, Besançon University, Faculty of Medicine, Besançon University Hospital, Paris, France
| | - Alexis Jean
- Internal Medicine Department, Bordeaux University, Faculty of Medicine, Bordeaux University Hospital, Bordeaux, France
| | - Marie Kostine
- Rheumatology Department, Bordeaux University, Faculty of Medicine, Bordeaux University Hospital, Bordeaux, France
| | - Valentin Lacombe
- Internal Medicine Department, Clermont-Ferrand University, Faculty of Medicine, Estaing University Hospital, Clermont-Ferrand, France
| | - Guillaume Le Guenno
- Internal Medicine and Clinical Immunology Department, Angers University, Faculty of Medicine, Angers University Hospital, Angers, France
| | - Hervé Lobbes
- Internal Medicine and Clinical Immunology Department, Angers University, Faculty of Medicine, Angers University Hospital, Angers, France
| | - Nadine Magy-Bertrand
- Internal Medicine Department, Besançon University, Faculty of Medicine, Besançon University Hospital, Paris, France
| | - Paola Marianetti-Guingel
- Internal Medicine Department, Reims University, Faculty of Medicine, Reims University Hospital, Reims, France
| | - Alexis Mathian
- Internal Medicine Department, Sorbonne University, Faculty of Medicine, AP-HP, Pitié-Salpêtrière University Hospital, Paris, France
| | - Rodérau Outh
- Internal Medicine Department, Perpignan Hospital Center, Perpignan, France
| | - Clémence Saillard
- Dermatology Department, Rennes University, Faculty of Medicine, Rennes University Hospital, Rennes, France
| | - Maxime Samson
- Internal Medicine Department, Bourgogne University, Faculty of Medicine, Dijon University Hospital, Dijon, France
| | - Guillaume Vial
- Internal Medicine Department, Bordeaux University, Faculty of Medicine, Bordeaux University Hospital, Bordeaux, France
| | - Jean-David Bouaziz
- Dermatology Department, Paris University, Faculty of Medicine, AP-HP, Saint Louis University Hospital, Paris, France
| | - Philippe Moguelet
- Pathology Department, Sorbonne University, Faculty of Medicine, AP-HP, Tenon University Hospital, Paris, France
| | - François Chasset
- Dermatology and Allergology Department, Sorbonne University, Faculty of Medicine, AP-HP, Tenon University Hospital, Paris, France.
| | | |
Collapse
|
5
|
Dupré A, Morel N, Yelnik C, Moguelet P, Le Guern V, Stammler R, Nguyen Y, Paule R, Dufrost V, Ackermann F, Benhamou Y, Godeau B, Lambert M, Duffau P, Mekinian A, Saadoun D, Mouthon L, Hachulla E, Maillard H, Levesque H, Morell-Dubois S, Leroux G, Piette JC, Chasset F, Costedoat-Chalumeau N. Cutaneous Involvement in Catastrophic Antiphospholipid Syndrome in a Multicenter Cohort of 65 Patients. JAMA Dermatol 2022; 159:62-67. [PMID: 36477813 PMCID: PMC9856595 DOI: 10.1001/jamadermatol.2022.5221] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
Importance Catastrophic antiphospholipid syndrome (CAPS) is a severe, rare complication of antiphospholipid syndrome (APS), but cutaneous involvement has not yet been adequately described. Objective To describe cutaneous involvement during CAPS, its clinical and pathological features, and outcomes. Design, Setting, and Participants This cohort study was a retrospective analysis of patients included in the French multicenter APS/systemic lupus erythematosus register (ClinicalTrials.gov: NCT02782039) by December 2020. All patients meeting the revised international classification criteria for CAPS were included, and patients with cutaneous manifestations were analyzed more specifically. Main Outcomes and Measures Clinical and pathological data as well as course and outcome in patients with cutaneous involvement during CAPS were collected and compared with those in the register without cutaneous involvement. Results Among 120 patients with at least 1 CAPS episode, the 65 (54%) with skin involvement (43 [66%] women; median [range] age, 31 [12-69] years) were analyzed. Catastrophic antiphospholipid syndrome was the first APS manifestation for 21 of 60 (35%) patients with available data. The main lesions were recent-onset or newly worsened livedo racemosa (n = 29, 45%), necrotic and/or ulcerated lesions (n = 27, 42%), subungual splinter hemorrhages (n = 19, 29%), apparent distal inflammatory edema (reddened and warm hands, feet, or face) (n = 15, 23%), and/or vascular purpura (n = 9, 14%). Sixteen biopsies performed during CAPS episodes were reviewed and showed microthrombi of dermal capillaries in 15 patients (94%). These lesions healed without sequelae in slightly more than 90% (58 of 64) of patients. Patients with cutaneous involvement showed a trend toward more frequent histologically proven CAPS (37% vs 24%, P = .16) than those without such involvement, while mortality did not differ significantly between the groups (respectively, 5% vs 9%, P = .47). Conclusions and Relevance In this cohort study, half the patients with CAPS showed cutaneous involvement, with a wide spectrum of clinical presentations, including distal inflammatory edema. Skin biopsies confirmed the diagnosis in all but 1 biopsied patient.
Collapse
Affiliation(s)
- Anastasia Dupré
- Assistance Publique–Hôpitaux de Paris, Centre Hospitalo-Universitaire Cochin, Service de Médecine Interne, Paris, France
| | - Nathalie Morel
- Assistance Publique–Hôpitaux de Paris, Centre Hospitalo-Universitaire Cochin, Service de Médecine Interne, Paris, France
| | - Cécile Yelnik
- Centre Hospitalo-Universitaire Claude Huriez, Service de Médecine Interne et Immunologie Clinique, Lille, France
| | - Philippe Moguelet
- Assistance Publique–Hôpitaux de Paris, Centre Hospitalo-Universitaire Tenon, Service d’Anatomopathologie, Paris, France
| | - Véronique Le Guern
- Assistance Publique–Hôpitaux de Paris, Centre Hospitalo-Universitaire Cochin, Service de Médecine Interne, Paris, France
| | - Romain Stammler
- Assistance Publique–Hôpitaux de Paris, Centre Hospitalo-Universitaire Cochin, Service de Médecine Interne, Paris, France
| | - Yann Nguyen
- Assistance Publique–Hôpitaux de Paris, Centre Hospitalo-Universitaire Cochin, Service de Médecine Interne, Paris, France
| | - Romain Paule
- Hôpital Foch, Service de Médecine Interne, Suresnes, France
| | - Virginie Dufrost
- Centre Hospitalier Régional et Universitaire de Nancy, Service de Médecine Vasculaire, Nancy, France
| | | | - Ygal Benhamou
- Normandie Université, UNIROUEN, U 1096, Centre Hospitalo-Universitaire, Service de Médecine Interne, Rouen, France
| | - Bertrand Godeau
- Assistance Publique–Hôpitaux de Paris, Centre Hospitalo-Universitaire Mondor, Service de Médecine Interne, Créteil, France
| | - Marc Lambert
- Centre Hospitalo-Universitaire Claude Huriez, Service de Médecine Interne et Immunologie Clinique, Lille, France
| | - Pierre Duffau
- Centre Hospitalo-Universitaire de Bordeaux, Service de Médecine Interne et Immunologie Clinique, Bordeaux, France
| | - Arsène Mekinian
- Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Centre Hospitalo-Universitaire Saint Antoine, service de médecine interne et Inflammation-Immunopathology-Biotherapy Department (DMU i3), Paris, France
| | - David Saadoun
- Assistance Publique–Hôpitaux de Paris, Centre Hospitalo-Universitaire La Pitié, Département de Médecine Interne et Immunologie Clinique, Paris, France
| | - Luc Mouthon
- Assistance Publique–Hôpitaux de Paris, Centre Hospitalo-Universitaire Cochin, Service de Médecine Interne, Paris, France
| | - Eric Hachulla
- Centre Hospitalo-Universitaire Claude Huriez, Service de Médecine Interne et Immunologie Clinique, Lille, France
| | - Hélène Maillard
- Centre Hospitalo-Universitaire Claude Huriez, Service de Médecine Interne et Immunologie Clinique, Lille, France
| | - Hervé Levesque
- Normandie Université, UNIROUEN, U 1096, Centre Hospitalo-Universitaire, Service de Médecine Interne, Rouen, France
| | - Sandrine Morell-Dubois
- Centre Hospitalo-Universitaire Claude Huriez, Service de Médecine Interne et Immunologie Clinique, Lille, France
| | - Gaëlle Leroux
- Assistance Publique–Hôpitaux de Paris, Centre Hospitalo-Universitaire La Pitié, Département de Médecine Interne et Immunologie Clinique, Paris, France
| | - Jean-Charles Piette
- Assistance Publique–Hôpitaux de Paris, Centre Hospitalo-Universitaire La Pitié, Département de Médecine Interne et Immunologie Clinique, Paris, France
| | - François Chasset
- Sorbonne Université, Faculté de Médecine, Assistance Publique–Hôpitaux de Paris, Centre Hospitalo-Universitaire Tenon, Service de Dermatologie, Paris, France
| | - Nathalie Costedoat-Chalumeau
- Assistance Publique–Hôpitaux de Paris, Centre Hospitalo-Universitaire Cochin, Service de Médecine Interne, Paris, France,Université de Paris, Centre de Recherche Épidémiologie et Biostatistiques de Sorbonne Paris Cité, Paris, France
| |
Collapse
|
6
|
Colboc H, Bazin D, Reguer S, Lucas IT, Moguelet P, Amode R, Jouanneau C, Soria A, Chasset F, Amsler E, Pecquet C, Aractingi S, Bellot-Gurlet L, Deschamps L, Descamps V, Kluger N. Chemical characterization of inks in skin reactions to tattoo. J Synchrotron Radiat 2022; 29:1436-1445. [PMID: 36345752 PMCID: PMC9641572 DOI: 10.1107/s1600577522008165] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 02/07/2022] [Accepted: 08/15/2022] [Indexed: 06/16/2023]
Abstract
Skin reactions are well described complications of tattooing, usually provoked by red inks. Chemical characterizations of these inks are usually based on limited subjects and techniques. This study aimed to determine the organic and inorganic composition of inks using X-ray fluorescence spectroscopy (XRF), X-ray absorption spectroscopy (XANES) and Raman spectroscopy, in a cohort of patients with cutaneous hypersensitivity reactions to tattoo. A retrospective multicenter study was performed, including 15 patients diagnosed with skin reactions to tattoos. Almost half of these patients developed skin reactions on black inks. XRF identified known allergenic metals - titanium, chromium, manganese, nickel and copper - in almost all cases. XANES spectroscopy distinguished zinc and iron present in ink from these elements in endogenous biomolecules. Raman spectroscopy showed the presence of both reported (azo pigments, quinacridone) and unreported (carbon black, phtalocyanine) putative organic sensitizer compounds, and also defined the phase in which Ti was engaged. To the best of the authors' knowledge, this paper reports the largest cohort of skin hypersensitivity reactions analyzed by multiple complementary techniques. With almost half the patients presenting skin reaction on black tattoo, the study suggests that black modern inks should also be considered to provoke skin reactions, probably because of the common association of carbon black with potential allergenic metals within these inks. Analysis of more skin reactions to tattoos is needed to identify the relevant chemical compounds and help render tattoo ink composition safer.
Collapse
Affiliation(s)
- Hester Colboc
- Sorbonne Université, Hôpital Rothschild, Service de Gériatrie-Plaies et Cicatrisation, Paris, France
- Sorbonne Université, UPMC Paris 06, Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche S 1155, F-75020 Paris, France
| | - Dominique Bazin
- Institut de Chimie Physique, Université Paris-Saclay, Orsay, France
| | - Solenn Reguer
- DiffAbs Beamline, Synchrotron SOLEIL, L’Orme des Merisiers, Départementale 128, 91190 Saint-Aubin, France
| | - Ivan T. Lucas
- Sorbonne Université, CNRS, Laboratoire Lise UMR 8235, Paris, France
| | - Philippe Moguelet
- Sorbonne Université, Hôpital Tenon, Anatomie et Cytologie Pathologiques, Paris, France
| | | | - Chantal Jouanneau
- Sorbonne Université, UPMC Paris 06, Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche S 1155, F-75020 Paris, France
| | - Angèle Soria
- Sorbonne Université, Hôpital Tenon, Service de Dermatologie-Allergologie, Paris, France
| | - François Chasset
- Sorbonne Université, Hôpital Tenon, Service de Dermatologie-Allergologie, Paris, France
| | - Emmanuelle Amsler
- Sorbonne Université, Hôpital Tenon, Service de Dermatologie-Allergologie, Paris, France
| | - Catherine Pecquet
- Sorbonne Université, Hôpital Tenon, Service de Dermatologie-Allergologie, Paris, France
| | - Sélim Aractingi
- Université de Paris, Hôpital Cochin, Service de Dermatologie, Paris, France
| | | | - Lydia Deschamps
- Université de Paris, Hôpital Bichat, Service d’Anatomie et Cytologie Pathologique, Paris, France
| | - Vincent Descamps
- Université de Paris, Hôpital Bichat, Service de Dermatologie, Paris, France
| | - Nicolas Kluger
- Université de Paris, Hôpital Bichat, Service de Dermatologie, Paris, France
- Department of Dermatology, Allergology and Venereology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland
| |
Collapse
|
7
|
Abbara S, Monfort JB, Savey L, Moguelet P, Saadoun D, Bachmeyer C, Fain O, Terrier B, Amoura Z, Mathian A, Gilardin L, Buob D, Job-Deslandre C, Dufour JF, Sberro-Soussan R, Grateau G, Georgin-Lavialle S. Vasculitis and familial Mediterranean fever: Description of 22 French adults from the juvenile inflammatory rheumatism cohort. Front Med (Lausanne) 2022; 9:1000167. [PMID: 36388918 PMCID: PMC9649929 DOI: 10.3389/fmed.2022.1000167] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2022] [Accepted: 10/11/2022] [Indexed: 01/27/2023] Open
Abstract
Objective The frequency of vasculitis may be increased in patients with Familial Mediterranean Fever (FMF), according to several studies. Our aim was to assess the characteristics of French adult patients with both diseases. Methods Patients with vasculitis were selected from patients followed for FMF in the French JIR-cohort. Results Twenty-two patients were included [polyarteritis nodosa (PAN) n = 10, IgA vasculitis n = 8, unclassified vasculitis n = 2, granulomatosis with polyangiitis n = 1, and microscopic polyangiitis n = 1]. Pathogenic mutations in exon 10 were found in all 21 patients (96%) for which MEFV testing results were available, and 18 (82%) had two pathogenic mutations. Histology showed vasculitis in 59% of patients. Most patients with FMF-associated PAN were HBV-negative and had an inactive FMF before PAN onset, and 40% had a peri-renal or central nervous system bleeding. Most patients with FMF-associated IgA vasculitis had an active FMF before vasculitis onset, and 25% had digestive bleeding. Both patients with unclassified vasculitis had ischemic and/or hemorrhagic complications. Conclusion This study confirms the predominance of PAN and IgA vasculitis in patients with FMF and the high frequency of bleeding in FMF-associated PAN. FMF should be considered in case of persistent symptoms and/or inflammatory syndrome despite vasculitis treatment in Mediterranean patients.
Collapse
Affiliation(s)
- Salam Abbara
- Département de Médecine Interne, Centre de Référence des Maladies Auto-Inflammatoires et des Amyloses d’Origine Inflammatoire (CEREMAIA), Hôpital Tenon, Sorbonne Université, AP-HP, Paris, France
| | - Jean-Benoit Monfort
- Département de Dermatologie, Hôpital Tenon, Sorbonne Université, AP-HP, Paris, France
| | - Léa Savey
- Département de Médecine Interne, Centre de Référence des Maladies Auto-Inflammatoires et des Amyloses d’Origine Inflammatoire (CEREMAIA), Hôpital Tenon, Sorbonne Université, AP-HP, Paris, France
| | - Philippe Moguelet
- Département d’Anatomo-Pathologie, Hôpital Tenon, Sorbonne Université, AP-HP, Paris, France
| | - David Saadoun
- Département de Médecine Interne et Immunologie Clinique, Centre National de Référence Maladies Autoimmunes Systémiques Rares, Centre National de Référence Maladies Autoinflammatoires et Amylose Inflammatoire, INSERM UMR_S 959, Immunologie-Immunopathologie-Immunotherapie, i3 and Département Hospitalo-Universitaire Inflammation-Immunopathologie-Biothérapie i2B, Groupe Hospitalier Pitié-Salpêtrière, Sorbonne Université, AP-HP, Paris, France
| | - Claude Bachmeyer
- Département de Médecine Interne, Centre de Référence des Maladies Auto-Inflammatoires et des Amyloses d’Origine Inflammatoire (CEREMAIA), Hôpital Tenon, Sorbonne Université, AP-HP, Paris, France
| | - Olivier Fain
- Service de Médecine Interne, Hôpital Saint-Antoine, Sorbonne Université, APHP, Paris, France
| | - Benjamin Terrier
- Service de Médecine Interne, Centre de Référence Maladies Systémiques et Autoimmunes Rares d’Ile de France, Hôpital Cochin, Université Paris Cité, AP-HP, Paris, France
| | - Zahir Amoura
- Service de Médecine Interne 2, Institut E3M, Inserm UMRS, Centre d’Immunologie et des Maladies Infectieuses (CIMI-Paris), French National Referral Center for Systemic Lupus Erythematosus, Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders, Groupement Hospitalier Pitié–Salpêtrière, Sorbonne Université, AP-HP, Paris, France
| | - Alexis Mathian
- Service de Médecine Interne 2, Institut E3M, Inserm UMRS, Centre d’Immunologie et des Maladies Infectieuses (CIMI-Paris), French National Referral Center for Systemic Lupus Erythematosus, Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders, Groupement Hospitalier Pitié–Salpêtrière, Sorbonne Université, AP-HP, Paris, France
| | - Laurent Gilardin
- Département de Médecine Interne et Immunologie Clinique, Groupe Hospitalier Pitié-Salpêtrière, Sorbonne Université, AP-HP, Paris, France
| | - David Buob
- Département d’Anatomo-Pathologie, Hôpital Tenon, Sorbonne Université, AP-HP, Paris, France
| | - Chantal Job-Deslandre
- Service de Pédiatrie, Immunologie, Hématologie et Rhumatologie, Centre de Référence pour les Rhumatismes Inflammatoires et les Maladies Auto-Immunes Systémique Rare de l’Enfant (RAISE), Hôpital Necker-Enfants Malades, AP-HP, Université Paris Cité, Paris, France
| | - Jean-François Dufour
- Service Médecine Interne, Hôpital Nord-Ouest, Centre Hospitalier Villefranche sur Saône, Gleize, France
| | - Rebecca Sberro-Soussan
- Service de Transplantation Rénale Adulte, Hôpital Necker-Enfants Malades, AP-HP, Université Paris Cité, Paris, France
| | - Gilles Grateau
- Département de Médecine Interne, Centre de Référence des Maladies Auto-Inflammatoires et des Amyloses d’Origine Inflammatoire (CEREMAIA), Hôpital Tenon, Sorbonne Université, AP-HP, Paris, France
| | - Sophie Georgin-Lavialle
- Département de Médecine Interne, Centre de Référence des Maladies Auto-Inflammatoires et des Amyloses d’Origine Inflammatoire (CEREMAIA), Hôpital Tenon, Sorbonne Université, AP-HP, Paris, France
- INSERM U938, Centre de Recherche Saint-Antoine (CRSA), Paris, France
- *Correspondence: Sophie Georgin-Lavialle,
| |
Collapse
|
8
|
Breillat P, Jachiet M, Ditchi Y, Lenormand C, Costedoat-Chalumeau N, Mathian A, Moguelet P, Duriez P, Trendelenburg M, Huynh-Do U, Chizzolini C, Beuvon C, Roy-Peaud F, Bouaziz JD, Barbaud A, Francès C, Mékinian A, Fain O, Amoura Z, Chasset F. Cutaneous vasculitis occurring in the setting of systemic lupus erythematosus: a multicenter cohort study. Rheumatology (Oxford) 2022:6747185. [PMID: 36190335 DOI: 10.1093/rheumatology/keac566] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2022] [Revised: 08/23/2022] [Accepted: 09/20/2022] [Indexed: 11/14/2022] Open
Abstract
OBJECTIVES To describe the clinical and pathological features of biopsy-proven cutaneous vasculitis (CV) associated with systemic lupus erythematosus (SLE), focusing on diagnosis classification and impact on overall SLE activity. METHODS Retrospective multicentric cohort study including SLE patients with biopsy-proven CV identified by 1) data from pathology departments of three university hospitals and 2) a national call for cases. SLE was defined according to 1997 revised ACR and/or 2019 ACR/EULAR criteria. CV diagnosis was confirmed histologically and classified by using the dermatological addendum of the Chapel Hill classification. SLE activity and flare severity at the time of CV diagnosis were assessed independently of vasculitis items with the SELENA-SLEDAI and SELENA-SLEDAI Flare Index. RESULTS Overall, 39 patients were included; 35 (90%) were female. Cutaneous manifestations included mostly palpable purpura (n = 21; 54%) and urticarial lesions (n = 18; 46%); lower limbs were the most common location (n = 33; 85%). Eleven (28%) patients exhibited extracutaneous vasculitis. A higher prevalence of Sjögren's syndrome (51%) was found compared with SLE patients without CV from the French referral center group (12%, p < 0.0001) and the Swiss SLE Cohort (11%, p < 0.0001). CV were mostly classified as urticarial vasculitis (n = 14, 36%) and cryoglobulinemia (n = 13, 33%). Only 2 (5%) patients had no other cause than SLE to explain the CV. Sixty-one percent of patients had inactive SLE. CONCLUSION SLE-related vasculitis seems very rare and other causes of vasculitis should be ruled out before considering this diagnosis. Moreover, in more than half of patients, CV was not associated with another sign of active SLE.
Collapse
Affiliation(s)
- Paul Breillat
- Sorbonne Université, Faculté de médecine, AP-HP, Service de Médecine interne 2, Hôpital Pitié Salpetrière, Paris, France
| | - Marie Jachiet
- Université de Paris, Faculté de médecine, AP-HP, Service de Dermatologie, Hôpital Saint-Louis, Paris, France
| | - Yoan Ditchi
- Sorbonne Université, Faculté de médecine, AP-HP, Service d'anatomo-pathologie, Hôpital Saint Antoine, Paris, France
| | - Cédric Lenormand
- Service de Dermatologie, Hôpital Civil - Hôpitaux Universitaires de Strasbourg, Strasbourg, France
| | - Nathalie Costedoat-Chalumeau
- Université de Paris cité, Faculté de médecine, AP-HP, Service de Médecine interne, Hôpital Cochin, Paris, France
| | - Alexis Mathian
- Sorbonne Université, Faculté de médecine, AP-HP, Service de Médecine interne 2, Hôpital Pitié Salpetrière, Paris, France
| | - Philippe Moguelet
- Sorbonne Université, Faculté de médecine, AP-HP, Service d'anatomo-pathologie, Hôpital Saint Antoine, Paris, France
| | - Paul Duriez
- Sorbonne Université, Faculté de médecine, AP-HP, Service d'anatomo-pathologie, Hôpital Saint Antoine, Paris, France
| | - Marten Trendelenburg
- Laboratory for Clinical Immunology, Department of Biomedicine and Division of Internal Medicine, University Hospital of Basel, Switzerland
| | - Uyen Huynh-Do
- Division of Nephrology and Hypertension, Inselspital, Bern University Hospital, Switzerland
| | - Carlo Chizzolini
- Pathology and Immunology, Centre Médical Universitaire, School of Medicine, Geneva, Switzerland.,Department of Pathology and Immunology, School of Medicine, Geneva, Switzerland
| | - Clément Beuvon
- Service de Médecine interne, Hôpitaux Universitaires de Poitiers, Poitiers, France
| | - Frederique Roy-Peaud
- Service de Médecine interne, Hôpitaux Universitaires de Poitiers, Poitiers, France
| | - Jean-David Bouaziz
- Université de Paris, Faculté de médecine, AP-HP, Service de Dermatologie, Hôpital Saint-Louis, Paris, France
| | - Annick Barbaud
- Sorbonne Université, Faculté de médecine, AP-HP, Service de Dermatologie et Allergologie, Hôpital Tenon, Paris, France
| | - Camille Francès
- Sorbonne Université, Faculté de médecine, AP-HP, Service de Dermatologie et Allergologie, Hôpital Tenon, Paris, France
| | - Arsène Mékinian
- Sorbonne Université, Faculté de médecine, AP-HP, Service de Médecine interne, Hôpital Saint-Antoine, Paris, France
| | - Olivier Fain
- Sorbonne Université, Faculté de médecine, AP-HP, Service de Médecine interne, Hôpital Saint-Antoine, Paris, France
| | - Zahir Amoura
- Sorbonne Université, Faculté de médecine, AP-HP, Service de Médecine interne 2, Hôpital Pitié Salpetrière, Paris, France
| | - François Chasset
- Sorbonne Université, Faculté de médecine, AP-HP, Service de Dermatologie et Allergologie, Hôpital Tenon, Paris, France
| | | | | |
Collapse
|
9
|
Colboc H, Bettuzzi T, Badrignans M, Bazin D, Boury A, Letavernier E, Frochot V, Tang E, Moguelet P, Ortonne N, de Prost N, Ingen-Housz-Oro S, Daudon M. Relationship between calcinosis cutis in epidermal necrolysis and caspofungin, a physicochemical investigation. CR CHIM 2022. [DOI: 10.5802/crchim.202] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
|
10
|
Colboc H, Moguelet P, Letavernier E, Frochot V, Bernaudin JF, Weil R, Rouzière S, Senet P, Bachmeyer C, Laporte N, Lucas I, Descamps V, Amode R, Brunet-Possenti F, Kluger N, Deschamps L, Dubois A, Reguer S, Somogyi A, Medjoubi K, Refregiers M, Daudon M, Bazin D. Pathologies related to abnormal deposits in dermatology: a physico-chemical approach. CR CHIM 2022. [DOI: 10.5802/crchim.153] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
|
11
|
Sola-Gazagnes A, Pecquet C, Berré S, Achenbach P, Pierson LA, Virmoux-Buisson I, M'Bemba J, Elgrably F, Moguelet P, Boitard C, Caillat-Zucman S, Laanani M, Coste J, Larger E, Mallone R. Insulin allergy: a diagnostic and therapeutic strategy based on a retrospective cohort and a case-control study. Diabetologia 2022; 65:1278-1290. [PMID: 35505238 DOI: 10.1007/s00125-022-05710-9] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/24/2022] [Accepted: 03/30/2022] [Indexed: 11/24/2022]
Abstract
AIMS/HYPOTHESIS Insulin allergy is a rare but significant clinical challenge. We aimed to develop a management workflow by (1) validating clinical criteria to guide diagnosis, based on a retrospective cohort, and (2) assessing the diagnostic performance of confirmatory tests, based on a case-control study. METHODS In the retrospective cohort, patients with suspected insulin allergy were classified into three likelihood categories according to the presence of all (likely insulin allergy; 26/52, 50%), some (possible insulin allergy; 9/52, 17%) or none (unlikely insulin allergy; 17/52, 33%) of four clinical criteria: (1) recurrent local or systemic immediate or delayed hypersensitivity reactions; (2) reactions elicited by each injection; (3) reactions centred on the injection sites; and (4) reactions observed by the investigator (i.e. in response to an insulin challenge test). All underwent intradermal reaction (IDR) tests. A subsequent case-control study assessed the diagnostic performance of IDR, skin prick and serum anti-insulin IgE tests in ten clinically diagnosed insulin allergy patients, 24 insulin-treated non-allergic patients and 21 insulin-naive patients. RESULTS In the retrospective cohort, an IDR test validated the clinical diagnosis in 24/26 (92%), 3/9 (33%) and 0/14 (0%) likely, possible and unlikely insulin allergy patients, respectively. In the case-control study, an IDR test was 80% sensitive and 100% specific and identified the index insulin(s). The skin prick and IgE tests had a marginal diagnostic value. Patients with IDR-confirmed insulin allergy were treated using a stepwise strategy. CONCLUSIONS/INTERPRETATION Subject to validation, clinical likelihood criteria can effectively guide diabetologists towards an insulin allergy diagnosis before undertaking allergology tests. An IDR test shows the best diagnostic performance. A progressive management strategy can subsequently be implemented. Continuous subcutaneous insulin infusion is ultimately required in most patients. CLINICALTRIALS gov: NCT01407640.
Collapse
Affiliation(s)
- Agnès Sola-Gazagnes
- Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires de Paris Centre-Université Paris Cité, Cochin Hospital, Service de Diabétologie et Immunologie Clinique, Paris, France.
| | - Catherine Pecquet
- Assistance Publique-Hôpitaux de Paris, Hôpital Tenon, Service d'Allergologie Dermatologie, Paris, France
| | - Stefano Berré
- Université Paris Cité, CNRS, Inserm, Institut Cochin, Paris, France
| | - Peter Achenbach
- Helmholtz Zentrum München, German Research Center for Environmental Health, Institute of Diabetes Research, Munich-Neuherberg, Germany
- Technical University of Munich, School of Medicine, Klinikum rechts der Isar, Forschergruppe Diabetes, Munich, Germany
| | - Laure-Anne Pierson
- Assistance Publique-Hôpitaux de Paris, Hôtel-Dieu, Service de Pharmacie, Pharmacologie, Toxicologie, Paris, France
| | - Isabelle Virmoux-Buisson
- Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires de Paris Centre-Université Paris Cité, Cochin Hospital, Service de Diabétologie et Immunologie Clinique, Paris, France
| | - Jocelyne M'Bemba
- Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires de Paris Centre-Université Paris Cité, Cochin Hospital, Service de Diabétologie et Immunologie Clinique, Paris, France
| | - Fabienne Elgrably
- Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires de Paris Centre-Université Paris Cité, Cochin Hospital, Service de Diabétologie et Immunologie Clinique, Paris, France
| | - Philippe Moguelet
- Assistance Publique-Hôpitaux de Paris, Hôpital Tenon, Service d'Anatomo-Pathologie, Sorbonne Université, Faculté de Médecine, Paris, France
| | - Christian Boitard
- Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires de Paris Centre-Université Paris Cité, Cochin Hospital, Service de Diabétologie et Immunologie Clinique, Paris, France
- Université Paris Cité, CNRS, Inserm, Institut Cochin, Paris, France
| | - Sophie Caillat-Zucman
- Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Laboratoire d'Immunologie, Paris, France
- Université Paris Cité, Inserm UMR976, Institut de Recherche Saint-Louis, Paris, France
| | - Moussa Laanani
- Université Paris Cité, Assistance Publique-Hôpitaux de Paris, Cochin Hospital, Biostatistics and Epidemiology Unit, Paris, France
| | - Joel Coste
- Université Paris Cité, Assistance Publique-Hôpitaux de Paris, Cochin Hospital, Biostatistics and Epidemiology Unit, Paris, France
| | - Etienne Larger
- Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires de Paris Centre-Université Paris Cité, Cochin Hospital, Service de Diabétologie et Immunologie Clinique, Paris, France
- Université Paris Cité, CNRS, Inserm, Institut Cochin, Paris, France
| | - Roberto Mallone
- Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires de Paris Centre-Université Paris Cité, Cochin Hospital, Service de Diabétologie et Immunologie Clinique, Paris, France
- Université Paris Cité, CNRS, Inserm, Institut Cochin, Paris, France
| |
Collapse
|
12
|
Darrigade A, Oulès B, Sohier P, Jullie M, Moguelet P, Barbaud A, Soria A, Vignier N, Lebrun‐Vignes B, Sanchez‐Pena P, Chosidow O, Beylot‐Barry M, Milpied B, Dupin N. Sweet‐like syndrome and Multiple COVID‐Arm syndrome following COVID‐19 vaccines: “Specific” patterns in a series of 192 patients. Br J Dermatol 2022; 187:615-617. [PMID: 35653233 PMCID: PMC9348464 DOI: 10.1111/bjd.21692] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2022] [Revised: 04/22/2022] [Accepted: 05/31/2022] [Indexed: 11/27/2022]
Affiliation(s)
- Anne‐Sophie Darrigade
- Department of Dermatology Saint‐André Hospital University Hospital of Bordeaux Bordeaux France
- FISARD French Investigators for Skin Adverse Reactions to Drugs of the French Society of Dermatology Paris France
| | - Bénédicte Oulès
- Department of Dermatology Cochin Hospital AP‐HP AP‐HP.Centre‐Université Paris Cité Paris France
- Cutaneous Biology Lab Institut Cochin INSERM U1016 Université Paris Cité UMR 8104 Paris France
| | - Pierre Sohier
- Cutaneous Biology Lab Institut Cochin INSERM U1016 Université Paris Cité UMR 8104 Paris France
- Department of Pathology Cochin Hospital AP‐HP AP‐HP.Centre‐Université Paris Cité Paris France
| | - Marie‐Laure Jullie
- Department of Pathology Haut‐Lévêque Hospital University Hospital of Bordeaux Pessac France
| | | | - Annick Barbaud
- FISARD French Investigators for Skin Adverse Reactions to Drugs of the French Society of Dermatology Paris France
- Sorbonne Université Department of Dermatology and Allergy APHP Tenon Hospital Paris France
| | - Angèle Soria
- FISARD French Investigators for Skin Adverse Reactions to Drugs of the French Society of Dermatology Paris France
- Sorbonne Université Department of Dermatology and Allergy APHP Tenon Hospital Paris France
| | - Nicolas Vignier
- Centre d’investigation Clinique Antilles Guyane Centre hospitalier de Cayenne Inserm CIC 1424 Cayenne France
- Department of infectious diseases Avicenne Hospital AP‐HP Université Sorbonne Paris Nord Bobigny France
- French Infectious Diseases Society (SPILF) Paris France
| | - Bénédicte Lebrun‐Vignes
- FISARD French Investigators for Skin Adverse Reactions to Drugs of the French Society of Dermatology Paris France
- Regional center of Pharmacovigilance Pitié‐Salpêtrière Hospital APHP Université Sorbonne France
| | - Paola Sanchez‐Pena
- FISARD French Investigators for Skin Adverse Reactions to Drugs of the French Society of Dermatology Paris France
- Department of Pharmacovigilance Pellegrin Hospital Bordeaux France
| | - Olivier Chosidow
- Department of Dermatology Henri Mondor Hospital Créteil France
- GrIDIST (Infectious and Sexually Transmitted Infections Group) of the French Society of Dermatology Paris France
- Research group Dynamyc Faculté de Santé de Créteil Ecole nationale vétérinaire d’Alfort USC ANSES Université Paris‐Est Créteil EA7380 Créteil France
| | - Marie Beylot‐Barry
- Department of Dermatology Saint‐André Hospital University Hospital of Bordeaux Bordeaux France
- Translational Research on Oncodermatology and Orphean skin diseases BoRdeaux Institute of onCology INSERM U1312 Université de Bordeaux
| | - Brigitte Milpied
- Department of Dermatology Saint‐André Hospital University Hospital of Bordeaux Bordeaux France
- FISARD French Investigators for Skin Adverse Reactions to Drugs of the French Society of Dermatology Paris France
| | - Nicolas Dupin
- Department of Dermatology Cochin Hospital AP‐HP AP‐HP.Centre‐Université Paris Cité Paris France
- Cutaneous Biology Lab Institut Cochin INSERM U1016 Université Paris Cité UMR 8104 Paris France
- GrIDIST (Infectious and Sexually Transmitted Infections Group) of the French Society of Dermatology Paris France
| | | |
Collapse
|
13
|
Russo B, Borowczyk J, Cacialli P, Moguelet P, Truchetet ME, Modaressi A, Brembilla N, Bertrand J, Boehncke WH, Chizzolini C. AB0125 IL-25 PARTICIPATES IN KERATINOCYTE-DRIVEN DERMAL MATRIX TURNOVER AND IS REDUCED IN SYSTEMIC SCLEROSIS (SSc) EPIDERMIS. Ann Rheum Dis 2022. [DOI: 10.1136/annrheumdis-2022-eular.344] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
BackgroundEvidence shows that dysfunctional SSc keratinocytes contribute to fibrosis by altering dermal homeostasis (1, 2). Whether interleukin-25 (IL-25), an IL-17 family member regulating many epidermal functions (3), takes part in skin fibrosis is unknown.ObjectivesTo investigate the role of IL-25 in skin fibrosis.MethodsThe expression of IL-25 was evaluated by immunofluorescence and in situ hybridization in 10 SSc and 7 healthy donors (HD) skin biopsies. Epidermal equivalents (EE) reconstituted by primary HD keratinocytes were used as a model to study transcriptomic changes induced by IL-25 in the epidermis. RNA expression profile in EE was characterized by RNAseq. The conditioned medium (CM) from primary SSc and HD keratinocytes primed with IL-25 was used to stimulate fibroblasts. IL-6, IL-8, MMP-1, type-I collagen (col-I), and fibronectin production by fibroblasts was assessed by ELISA.ResultsSSc epidermis expressed lower levels of IL-25 compared to HD. In EE, IL-25 regulated several molecular pathways related to wound healing and extracellular matrix (ECM) remodeling. Compared to control CM, the CM from IL-25-primed keratinocytes enhanced the fibroblast production of MMP-1, IL-6, IL-8, but not of Col-I nor fibronectin. However, IL-25 significantly reduced the production of Col-I when applied directly to fibroblasts and partially inhibit α-smooth muscle actin (α-SMA) expression promoted by TGFβ. The activation of keratinocytes by IL-25 was receptor-dependent and evident after a very short incubation time (10 min), largely mediated by IL-1, suggesting enhanced and specific release of preformed mediators.ConclusionThese results show that IL-25 participates to skin homeostasis and its decreased expression in SSc may contribute to skin fibrosis by favoring ECM deposition over degradation.References[1]Russo B, Brembilla NC, Chizzolini C. Interplay between Keratinocytes and Fibroblasts: A Systematic Review Providing a New Angle for Understanding Skin Fibrotic Disorders. Frontiers in immunology. 2020; 11:648.[2]Russo B, Borowczyk J, Boehncke WH, Truchetet ME, Modarressi A, Brembilla NC, et al. Dysfunctional keratinocytes increase dermal inflammation in systemic sclerosis. Results from tissue-engineered scleroderma epidermis. Arthritis & rheumatology. 2021.[3]Borowczyk J, Shutova M, Brembilla NC, Boehncke WH. IL-25 (IL-17E) in epithelial immunology and pathophysiology. J Allergy Clin Immunol. 2021.AcknowledgementsWe thank Natacha Civic and Mylène Docquier (Genomics Platform) for performing the RNA sequencing; Nicolas Laudet (Bioimaging Core Facility) for quantification of immune-histology, François Prodon and Olivier Brun for microscope imaging (Bioimaging Core Facility), Marie Ebrahim Malek and Laura de Luca (Histology Core Facility) for contribution to tissue preparation (all at University Medical Center, Geneva, Switzerland).Disclosure of InterestsBarbara Russo: None declared, Julia Borowczyk: None declared, Pietro Cacialli: None declared, Philippe Moguelet: None declared, Marie-Elise Truchetet Speakers bureau: Abbvie, Lilly, SOBI and Boehringer Ingelheim, Ali Modaressi: None declared, Nicolò Brembilla: None declared, Julian Bertrand: None declared, Wolf-Henning Boehncke Speakers bureau: Abbvie, Almirall, BMS, Celgene, Leo, Lilly, Novartis, and UCB, Carlo Chizzolini Speakers bureau: GSK, Roche, Boehringer Ingelheim
Collapse
|
14
|
Savina A, Jaffredo T, Saldmann F, Faulkes CG, Moguelet P, Leroy C, Marmol DD, Codogno P, Foucher L, Zalc A, Viltard M, Friedlander G, Aractingi S, Fontaine RH. Single-cell transcriptomics reveals age-resistant maintenance of cell identities, stem cell compartments and differentiation trajectories in long-lived naked mole-rats skin. Aging (Albany NY) 2022; 14:3728-3756. [PMID: 35507806 PMCID: PMC9134947 DOI: 10.18632/aging.204054] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2021] [Accepted: 04/25/2022] [Indexed: 11/25/2022]
Abstract
Naked mole-rats (NMR) are subterranean rodents characterized by an unusual longevity coupled with an unexplained resistance to aging. In the present study, we performed extensive in situ analysis and single-cell RNA-sequencing comparing young and older animals. At variance with other species, NMR exhibited a striking stability of skin compartments and cell types, which remained stable over time without aging-associated changes. Remarkably, the number of stem cells was constant throughout aging. We found three classical cellular states defining a unique keratinocyte differentiation trajectory that were not altered after pseudo-temporal reconstruction. Epidermal gene expression did not change with aging either. Langerhans cell clusters were conserved, and only a higher basal stem cell expression of Igfbp3 was found in aged animals. In accordance, NMR skin healing closure was similar in young and older animals. Altogether, these results indicate that NMR skin is characterized by peculiar genetic and cellular features, different from those previously demonstrated for mice and humans. The remarkable stability of the aging NMR skin transcriptome likely reflects unaltered homeostasis and resilience.
Collapse
Affiliation(s)
| | - Thierry Jaffredo
- Institut de Biologie Paris Seine (IBPS), Laboratoire de Biologie du Développement, Sorbonne Université, CNRS, INSERM, Paris, France
| | | | - Chris G Faulkes
- Queen Mary University of London, School of Biological and Chemical Sciences, London, United Kingdom
| | - Philippe Moguelet
- Service d'Anatomie et Cytologie Pathologiques, Hôpital Tenon, Assistance Publique-Hôpitaux de Paris, Paris, France
| | - Christine Leroy
- Université Paris Cité, CNRS, INSERM, Institut Necker-Enfants Malades, Paris, France
| | | | - Patrice Codogno
- Université Paris Cité, CNRS, INSERM, Institut Necker-Enfants Malades, Paris, France
| | - Lucy Foucher
- Ecole Nationale Vétérinaire d'Alfort, Centre de Recherche Biomédicale, Maisons-Alfort, France
| | - Antoine Zalc
- Université Paris Cité, CNRS, INSERM, Institut Cochin, Paris, France
| | - Mélanie Viltard
- Fondation pour la Recherche en Physiologie, Brussels, Belgium
| | - Gérard Friedlander
- Université Paris Cité, CNRS, INSERM, Institut Necker-Enfants Malades, Paris, France
| | - Selim Aractingi
- Université Paris Cité, CNRS, INSERM, Institut Cochin, Paris, France.,Service de Dermatologie, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, France
| | | |
Collapse
|
15
|
Russo B, Borowczyk J, Cacialli P, Moguelet P, Truchetet ME, Modarressi A, Brembilla NC, Bertrand J, Boehncke WH, Chizzolini C. IL-25 participates in keratinocyte-driven dermal matrix turnover and is reduced in Systemic Sclerosis epidermis. Rheumatology (Oxford) 2022; 61:4558-4569. [PMID: 35171244 DOI: 10.1093/rheumatology/keac044] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2021] [Revised: 01/03/2022] [Indexed: 11/12/2022] Open
Abstract
OBJECTIVES Evidence shows that dysfunctional SSc keratinocytes contribute to fibrosis by altering dermal homeostasis. Whether interleukin-25 (IL-25), an IL-17 family member regulating many epidermal functions, takes part in skin fibrosis is unknown. Here we address the role of IL-25 in skin fibrosis. METHODS The expression of IL-25 was evaluated by immunofluorescence and in situ hybridization in 10 SSc and 7 healthy donors (HD) skin biopsies. Epidermal equivalents (EE) reconstituted by primary HD keratinocytes were used as a model to study transcriptomic changes induced by IL-25 in the epidermis. RNA expression profile in EE was characterized by RNAseq. The conditioned medium (CM) from primary SSc and HD keratinocytes primed with IL-25 was used to stimulate fibroblasts. IL-6, IL-8, MMP-1, type-I collagen (col-I), and fibronectin production by fibroblasts was assessed by ELISA. RESULTS SSc epidermis expressed lower levels of IL-25 compared with HD. In EE, IL-25 regulated several molecular pathways related to wound healing and ECM remodeling. Compared with control CM, the CM from IL-25-primed keratinocytes enhanced the fibroblast production of MMP-1, IL-6, IL-8, but not of Col-I nor fibronectin. However, IL-25 significantly reduced the production of Col-I when applied directly to fibroblasts. The activation of keratinocytes by IL-25 was receptor-dependent and evident after a very short incubation time (10 min), largely mediated by IL-1, suggesting enhanced and specific release of preformed mediators. CONCLUSIONS These results show that IL-25 participates to skin homeostasis and its decreased expression in SSc may contribute to skin fibrosis by favoring ECM deposition over degradation.
Collapse
Affiliation(s)
- Barbara Russo
- Pathology & Immunology, School of Medicine, University of Geneva, Switzerland.,Department of Dermatology, University Hospital and School of Medicine, University of Geneva, Switzerland
| | - Julia Borowczyk
- Pathology & Immunology, School of Medicine, University of Geneva, Switzerland
| | - Pietro Cacialli
- Pathology & Immunology, School of Medicine, University of Geneva, Switzerland
| | | | | | - Ali Modarressi
- Plastic, reconstructive & aesthetic unit, University Hospital and School of Medicine, Geneva, Switzerland
| | - Nicolò C Brembilla
- Pathology & Immunology, School of Medicine, University of Geneva, Switzerland.,Department of Dermatology, University Hospital and School of Medicine, University of Geneva, Switzerland
| | - Julien Bertrand
- Pathology & Immunology, School of Medicine, University of Geneva, Switzerland
| | - Wolf-Henning Boehncke
- Pathology & Immunology, School of Medicine, University of Geneva, Switzerland.,Department of Dermatology, University Hospital and School of Medicine, University of Geneva, Switzerland
| | - Carlo Chizzolini
- Pathology & Immunology, School of Medicine, University of Geneva, Switzerland.,Immunology & Allergy, Department of internal medicine, University Hospital and School of Medicine, Geneva, Switzerland
| |
Collapse
|
16
|
Colboc H, Bettuzzi T, Badrignans M, Bazin D, Boury A, Letavernier E, Frochot V, Tang E, Moguelet P, Ortonne N, de Prost N, Ingen-Housz-Oro S. Calcinosis cutis in epidermal necrolysis: role of caspofungin? J Eur Acad Dermatol Venereol 2021; 36:e313-e315. [PMID: 34758165 DOI: 10.1111/jdv.17808] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Affiliation(s)
- H Colboc
- Service Plaies et Cicatrisation, Sorbonne Université, Hôpital Rothschild, Paris, France.,UMR_S 1155, Sorbonne Université-UPMC Paris 06, Paris, France
| | - T Bettuzzi
- Service de Dermatologie, Hôpital Henri Mondor, Assistance Publique Hôpitaux de Paris, Créteil, France.,Univ Paris Est Créteil, EpiDermE, Créteil, France.,Reference Center for Toxic Bullous Dermatoses and Severe Drug Reactions TOXIBUL, Créteil, France
| | - M Badrignans
- Service de Pathologie, Hôpital Henri Mondor, Assistance Publique Hôpitaux de Paris, Créteil, France
| | - D Bazin
- CNRS, IPC, Ba340, Université Paris XI, Orsay, France
| | - A Boury
- CNRS, IPC, Ba340, Université Paris XI, Orsay, France
| | - E Letavernier
- UMR_S 1155, Sorbonne Université-UPMC Paris 06, Paris, France.,Service des Explorations Fonctionnelles Multidisciplinaires, Sorbonne Université, Hôpital Tenon, Paris, France
| | - V Frochot
- UMR_S 1155, Sorbonne Université-UPMC Paris 06, Paris, France.,Service des Explorations Fonctionnelles Multidisciplinaires, Sorbonne Université, Hôpital Tenon, Paris, France
| | - E Tang
- UMR_S 1155, Sorbonne Université-UPMC Paris 06, Paris, France
| | - P Moguelet
- Service de Pathologie, Sorbonne Université, Hôpital Tenon, Paris, France
| | - N Ortonne
- Reference Center for Toxic Bullous Dermatoses and Severe Drug Reactions TOXIBUL, Créteil, France
| | - N de Prost
- Service de Réanimation Médicale, Hôpital Henri Mondor, Assistance Publique Hôpitaux de Paris, Créteil, France
| | - S Ingen-Housz-Oro
- Service de Dermatologie, Hôpital Henri Mondor, Assistance Publique Hôpitaux de Paris, Créteil, France.,Univ Paris Est Créteil, EpiDermE, Créteil, France.,Reference Center for Toxic Bullous Dermatoses and Severe Drug Reactions TOXIBUL, Créteil, France
| |
Collapse
|
17
|
Brehon A, Moguelet P, Seta V, Amsler E, Fajac A, Barbaud A, Soria A, Monfort JB. Clinical and histological characteristics during chronic urticaria with dermal neutrophilic infiltrate: Proposal of a diagnostic score. J Eur Acad Dermatol Venereol 2021; 36:e304-e306. [PMID: 34742165 DOI: 10.1111/jdv.17788] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/26/2021] [Revised: 09/22/2021] [Accepted: 10/22/2021] [Indexed: 11/29/2022]
Affiliation(s)
- A Brehon
- AP-HP, Service de Dermatologie et Allergologie, Hôpital Tenon, Sorbonne Université, Paris, 75020, France
| | - P Moguelet
- AP-HP, Service de Pathologie, Hôpital Tenon, Sorbonne Université, Paris, 75020, France
| | - V Seta
- AP-HP, Service de Dermatologie, Hôpital Cochin, Université de Paris, Paris, 75014, France.,Service de Chirurgie Maxillo-Faciale, Chirurgie Orale et Stomatologie, CHU d'Angers, Angers, France
| | - E Amsler
- AP-HP, Service de Dermatologie et Allergologie, Hôpital Tenon, Sorbonne Université, Paris, 75020, France
| | - A Fajac
- AP-HP, Service de Pathologie, Hôpital Tenon, Sorbonne Université, Paris, 75020, France
| | - A Barbaud
- AP-HP, Service de Dermatologie et Allergologie, Hôpital Tenon, Sorbonne Université, Paris, 75020, France
| | - A Soria
- AP-HP, Service de Dermatologie et Allergologie, Hôpital Tenon, Sorbonne Université, Paris, 75020, France
| | - J B Monfort
- AP-HP, Service de Dermatologie et Allergologie, Hôpital Tenon, Sorbonne Université, Paris, 75020, France
| |
Collapse
|
18
|
Assan F, Bottin L, Francès C, Moguelet P, Tavolaro S, Barbaud A, de Zuttere D, Alamowitch S, Chasset F. Antiphospholipid-negative Sneddon's syndrome: A comprehensive overview of a rare entity. Ann Dermatol Venereol 2021; 149:3-13. [PMID: 34740467 DOI: 10.1016/j.annder.2021.08.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2021] [Revised: 05/26/2021] [Accepted: 08/04/2021] [Indexed: 11/24/2022]
Abstract
The term Sneddon's syndrome (SS) has been used since 1965 to describe a vasculopathy characterized by a combination of cerebrovascular disease with livedo racemosa. SS may be classified as antiphospholipid+ (aPL+) or antiphospholipid- (aPL-). Little is known about aPL- SS; in this review we describe the epidemiology and pathogenesis of aPL- SS, as well as the clinical and histologic features. We discuss recent findings in terms of neurologic and cardiac involvement. Moreover, differential diagnoses of conditions that may present with both livedo racemosa and stroke are discussed. Finally, we discuss real-life practical issues such as the initial investigations to be performed, long-term follow-up, and therapeutic management of aPL- SS patients.
Collapse
Affiliation(s)
- F Assan
- Sorbonne University, Faculté de Médecine Sorbonne Université, AP-HP, Service de Dermatologie et Allergologie, Hôpital Tenon, 75020 Paris, France
| | - L Bottin
- Sorbonne University, Faculté de Médecine Sorbonne Université, AP-HP, Service de Neurologie, Hôpital Saint-Antoine, 75012 Paris, France
| | - C Francès
- Sorbonne University, Faculté de Médecine Sorbonne Université, AP-HP, Service de Dermatologie et Allergologie, Hôpital Tenon, 75020 Paris, France
| | - P Moguelet
- Sorbonne University, Faculté de Médecine Sorbonne Université, AP-HP, Service de Pathologie, Hôpital Tenon, 75020 Paris, France
| | - S Tavolaro
- Sorbonne University, Faculté de Médecine Sorbonne Université, AP-HP, Service de Radiologie, Hôpital Tenon, 75020 Paris, France
| | - A Barbaud
- Sorbonne University, Faculté de Médecine Sorbonne Université, AP-HP, Service de Dermatologie et Allergologie, Hôpital Tenon, 75020 Paris, France
| | - D de Zuttere
- Service d'Explorations Fonctionnelles, Hôpital Franco-Britannique, 92300 Levallois-Perret, France
| | - S Alamowitch
- Sorbonne University, Faculté de Médecine Sorbonne Université, AP-HP, Service de Neurologie, Hôpital Saint-Antoine, 75012 Paris, France
| | - F Chasset
- Sorbonne University, Faculté de Médecine Sorbonne Université, AP-HP, Service de Dermatologie et Allergologie, Hôpital Tenon, 75020 Paris, France.
| |
Collapse
|
19
|
Allali S, Chasset F, Kirova Y, Saint-Martin C, Moguelet P, Fourquet A, Beddok A. Unusual severe radiation-induced toxicity in a patient with discoid lupus erythematosus: A case report and critical review of the literature. Cancer Radiother 2021; 26:594-598. [PMID: 34728115 DOI: 10.1016/j.canrad.2021.07.039] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2021] [Revised: 07/01/2021] [Accepted: 07/08/2021] [Indexed: 10/19/2022]
Abstract
Data on the incidence and severity of radiation-induced toxicity in patients with systemic and/or cutaneous lupus erythematosus (SLE/CLE) are very limited. After reporting the case of a patient who experienced major toxicity and CLE flare in the irradiated area following breast irradiation, we conducted a comprehensive literature review of available data in this setting. The few retrospectives studies which have evaluated both the risk of toxicity in SLE/CLE patients and/or the potential induction or reactivation of SLE/CLE with radiotherapy have not shown differences between SLE/CLE patients and controls. Several other factors such as concurrent chemotherapy, a particular genetic background, or lupus treatments (essentially hydroxychloroquine) can explain severe radiation-induced toxicity. Therefore, patients with SLE/CLE should be irradiated like patients without SLE/CLE, with close monitoring during radiotherapy if other risk factors exist. Further studies examining a larger number of patients would probably allow a better understanding of the radiosensitivity of these patients.
Collapse
Affiliation(s)
- S Allali
- Department of Radiation Oncology, Institut Curie, Paris, France
| | - F Chasset
- Sorbonne Université, Faculté de Médecine, AP-HP, Service de Dermatologie et Allergologie, Hôpital Tenon, 75020 Paris, France
| | - Y Kirova
- Department of Radiation Oncology, Institut Curie, Paris, France
| | - C Saint-Martin
- Department of statistics, Institut Curie, Saint-Cloud, France
| | - P Moguelet
- Department of Pathology, Tenon University Hospital, Paris, France
| | - A Fourquet
- Department of Radiation Oncology, Institut Curie, Paris, France
| | - A Beddok
- Department of Radiation Oncology, Institut Curie, Paris, France.
| |
Collapse
|
20
|
Martin de Frémont G, Hirsch P, Gimenez de Mestral S, Moguelet P, Ditchi Y, Emile JF, Senet P, Georgin-Lavialle S, Hanslik T, Maurier F, Adedjouma A, Abisror N, Mahevas T, Malard F, Adès L, Fenaux P, Fain O, Chasset F, Mekinian A. Myeloid Clonal Infiltrate Identified With Next-Generation Sequencing in Skin Lesions Associated With Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: A Case Series. Front Immunol 2021; 12:715053. [PMID: 34671345 PMCID: PMC8521190 DOI: 10.3389/fimmu.2021.715053] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2021] [Accepted: 09/02/2021] [Indexed: 11/13/2022] Open
Abstract
Background Myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML) are associated with cutaneous manifestations. Next-generation sequencing (NGS) is a tool capable of identifying clonal myeloid cells in the skin infiltrate and thus better characterize the link between hematological diseases and skin lesions. Objective To assess whether skin lesions of MDS/CMML are clonally related to blood or bone marrow cells using NGS. Methods Comparisons of blood or bone marrow and skin samples NGS findings from patients presenting with MDS/CMML and skin lesions in three French hospitals. Results Among the 14 patients recruited, 12 patients (86%) had mutations in the skin lesions biopsied, 12 patients (86%) had a globally similar mutational profile between blood/bone marrow and skin, and 10 patients (71%) had mutations with a high variant allele frequency (>10%) found in the myeloid skin infiltrate. Mutations in TET2 and DNMT3A, both in four patients, were the most frequent. Two patients harbored a UBA1 mutation on hematopoietic samples. Limitations Limited number of patients and retrospective collection of the data. Blood and skin sampling were not performed at the exact same time point for two patients. Conclusion Skin lesions in the setting of MDS/CMML are characterized by a clonal myeloid infiltrate in most cases.
Collapse
Affiliation(s)
- Grégoire Martin de Frémont
- Sorbonne Université, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint-Antoine, Service de Médecine Interne et Inflammation-[Département Médico-Universitaire (DMU)-i3], Université Paris 06, Paris, France
| | - Pierre Hirsch
- Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine, AP-HP, Hôpital Saint-Antoine, Service d'Hématologie Biologique, Université Paris 06, Paris, France
| | - Santiago Gimenez de Mestral
- Sorbonne Université, AP-HP, Hôpital Saint-Antoine, Service d'Anatomopathologie, Université Paris 06, Paris, France
| | - Philippe Moguelet
- Service d'Anatomopathologie, Hôpital Ambroise Paré, Assistance Publique Hôpitaux de Paris (APHP) and Université de Versailles Saint Quentin en Yvelines, Boulogne Billancourt, France
| | - Yoan Ditchi
- Sorbonne Université, AP-HP, Hôpital Saint-Antoine, Service d'Anatomopathologie, Université Paris 06, Paris, France
| | - Jean-François Emile
- Sorbonne Université, AP-HP, Hôpital Tenon, Service d'Anatomopathologie, Université Paris 06, Paris, France
| | - Patricia Senet
- Sorbonne Université, AP-HP, Hôpital Tenon, Service de Dermatologie, Université Paris 06, Paris, France
| | - Sophie Georgin-Lavialle
- Sorbonne Université, AP-HP, Hôpital Tenon, Service de Médecine Interne, Université Paris 06, Paris, France
| | - Thomas Hanslik
- Service de Médecine Interne, Hôpital Ambroise Paré, Assistance Publique Hôpitaux de Paris (APHP) and Université de Versailles Saint Quentin en Yvelines, Boulogne Billancourt, France
| | - François Maurier
- Service de Médecine Interne et Immunologie Clinique, Groupe Hospitalier UNEOS, Metz, France
| | - Amir Adedjouma
- Sorbonne Université, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint-Antoine, Service de Médecine Interne et Inflammation-[Département Médico-Universitaire (DMU)-i3], Université Paris 06, Paris, France
| | - Noémie Abisror
- Sorbonne Université, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint-Antoine, Service de Médecine Interne et Inflammation-[Département Médico-Universitaire (DMU)-i3], Université Paris 06, Paris, France
| | - Thibault Mahevas
- Sorbonne Université, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint-Antoine, Service de Médecine Interne et Inflammation-[Département Médico-Universitaire (DMU)-i3], Université Paris 06, Paris, France
| | - Florent Malard
- Sorbonne Université, AP-HP, Hôpital Saint-Antoine, Service d'Hématologie Clinique, Université Paris 06, Paris, France
| | - Lionel Adès
- Service d'Hématologie-Sénior, Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris (APHP) and Université de Paris, Paris, France
| | - Pierre Fenaux
- Service d'Hématologie-Sénior, Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris (APHP) and Université de Paris, Paris, France
| | - Olivier Fain
- Sorbonne Université, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint-Antoine, Service de Médecine Interne et Inflammation-[Département Médico-Universitaire (DMU)-i3], Université Paris 06, Paris, France
| | - François Chasset
- Sorbonne Université, AP-HP, Hôpital Tenon, Service de Dermatologie, Université Paris 06, Paris, France
| | - Arsène Mekinian
- Sorbonne Université, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint-Antoine, Service de Médecine Interne et Inflammation-[Département Médico-Universitaire (DMU)-i3], Université Paris 06, Paris, France
| |
Collapse
|
21
|
Stackowicz J, Gaudenzio N, Serhan N, Conde E, Godon O, Marichal T, Starkl P, Balbino B, Roers A, Bruhns P, Jönsson F, Moguelet P, Georgin-Lavialle S, Broderick L, Hoffman HM, Galli SJ, Reber LL. Neutrophil-specific gain-of-function mutations in Nlrp3 promote development of cryopyrin-associated periodic syndrome. J Exp Med 2021; 218:212620. [PMID: 34477811 PMCID: PMC8421266 DOI: 10.1084/jem.20201466] [Citation(s) in RCA: 28] [Impact Index Per Article: 9.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2020] [Revised: 06/10/2021] [Accepted: 07/30/2021] [Indexed: 12/14/2022] Open
Abstract
Gain-of-function mutations in NLRP3 are responsible for a spectrum of autoinflammatory diseases collectively referred to as “cryopyrin-associated periodic syndromes” (CAPS). Treatment of CAPS patients with IL-1–targeted therapies is effective, confirming a central pathogenic role for IL-1β. However, the specific myeloid cell population(s) exhibiting inflammasome activity and sustained IL-1β production in CAPS remains elusive. Previous reports suggested an important role for mast cells (MCs) in this process. Here, we report that, in mice, gain-of-function mutations in Nlrp3 restricted to neutrophils, and to a lesser extent macrophages/dendritic cells, but not MCs, are sufficient to trigger severe CAPS. Furthermore, in patients with clinically established CAPS, we show that skin-infiltrating neutrophils represent a substantial biological source of IL-1β. Together, our data indicate that neutrophils, rather than MCs, can represent the main cellular drivers of CAPS pathology.
Collapse
Affiliation(s)
- Julien Stackowicz
- Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR 1222, Institut national de la santé et de la recherche médicale, Paris, France.,Sorbonne Université, Paris, France
| | - Nicolas Gaudenzio
- Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), Institut national de la santé et de la recherche médicale, UMR 1291, Centre National de la Recherche Scientifique, UMR 5051, University of Toulouse III, Toulouse, France
| | - Nadine Serhan
- Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), Institut national de la santé et de la recherche médicale, UMR 1291, Centre National de la Recherche Scientifique, UMR 5051, University of Toulouse III, Toulouse, France
| | - Eva Conde
- Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR 1222, Institut national de la santé et de la recherche médicale, Paris, France
| | - Ophélie Godon
- Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR 1222, Institut national de la santé et de la recherche médicale, Paris, France
| | - Thomas Marichal
- GIGA-Research and Faculty of Veterinary Medicine, Liège University, Liège, Belgium
| | - Philipp Starkl
- Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.,Research Laboratory of Infection Biology, Department of Medicine I, Medical University of Vienna, Vienna, Austria
| | - Bianca Balbino
- Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR 1222, Institut national de la santé et de la recherche médicale, Paris, France.,Sorbonne Université, Paris, France
| | - Axel Roers
- Institute for Immunology, Medical Faculty Carl Gustav Carus, University of Technology Dresden, Dresden, Germany
| | - Pierre Bruhns
- Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR 1222, Institut national de la santé et de la recherche médicale, Paris, France
| | - Friederike Jönsson
- Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR 1222, Institut national de la santé et de la recherche médicale, Paris, France
| | - Philippe Moguelet
- Faculty of Medicine, Sorbonne University, Tenon Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France
| | - Sophie Georgin-Lavialle
- Internal Medicine Department, Tenon Hospital, Assistance Publique - Hôpitaux de Paris, Sorbonne University, Paris, France
| | - Lori Broderick
- Division of Pediatric Allergy, Immunology and Rheumatology, University of California, San Diego, and Rady Children's Hospital, San Diego, CA
| | - Hal M Hoffman
- Division of Pediatric Allergy, Immunology and Rheumatology, University of California, San Diego, and Rady Children's Hospital, San Diego, CA
| | - Stephen J Galli
- Department of Pathology, Stanford University School of Medicine, Stanford, CA.,Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA.,Sean N. Parker Center for Allergy and Asthma Research, Stanford University School of Medicine, Stanford, CA
| | - Laurent L Reber
- Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR 1222, Institut national de la santé et de la recherche médicale, Paris, France.,Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), Institut national de la santé et de la recherche médicale, UMR 1291, Centre National de la Recherche Scientifique, UMR 5051, University of Toulouse III, Toulouse, France
| |
Collapse
|
22
|
Bourguiba R, Bachmeyer C, Moguelet P, Kaaki S, Ory C, Touchard G, Cattan E, Georgin-Lavialle S, Colombat M, Valleix S. LC-MS/MS and immuno-electron subtyping combined with genetics show that OSMR mutations cause amyloid deposition of keratins 5/14 in familial primary localized cutaneous amyloidosis. J Eur Acad Dermatol Venereol 2021; 36:e66-e68. [PMID: 34459039 DOI: 10.1111/jdv.17630] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2021] [Accepted: 07/29/2021] [Indexed: 11/27/2022]
Affiliation(s)
- R Bourguiba
- Service de Médecine Interne, Hôpital Tenon, AP-HP, Paris, France
| | - C Bachmeyer
- Service de Médecine Interne, Hôpital Tenon, AP-HP, Paris, France
| | - P Moguelet
- Service d'Anatomo-Pathologie, Hôpital Tenon, AP-HP, Paris, France
| | - S Kaaki
- Service d'Anatomie et Cytologie Pathologique, Unité de Pathologie Ultrastructurale, CHU Poitiers and Centre de Référence Amylose AL et autres maladies à dépôts d'immunoglobulines monoclonales, CHU Poitiers, Poitiers, France
| | - C Ory
- Service d'Anatomie et Cytologie Pathologique, Unité de Pathologie Ultrastructurale, CHU Poitiers and Centre de Référence Amylose AL et autres maladies à dépôts d'immunoglobulines monoclonales, CHU Poitiers, Poitiers, France
| | - G Touchard
- Service d'Anatomie et Cytologie Pathologique, Unité de Pathologie Ultrastructurale, CHU Poitiers and Centre de Référence Amylose AL et autres maladies à dépôts d'immunoglobulines monoclonales, CHU Poitiers, Poitiers, France
| | - E Cattan
- Cabinet de Dermatologie, Pantin, France
| | | | - M Colombat
- Service d'Anatomie et Cytologie Pathologique, Institut Universitaire du Cancer, CHU Toulouse, Université Paul Sabatier, Toulouse, France
| | - S Valleix
- Laboratoire de Biologie et Génétique Moléculaires, Hôpital Cochin, AP-HP.CUP, Université de Paris, Paris, France
| |
Collapse
|
23
|
Lemasson J, Frumholtz L, Jachiet M, Lenormand C, Lipsker D, Moulin S, Chiaverini C, Le Duff F, Passeron T, Cordoliani F, Bagot M, Monfort JB, Senet P, De Masson A, Cassius C, Petit A, Misery L, Moguelet P, Cordel N, Fardet L, Begon E, Frances C, Bessis D, Bouaziz JD, Chasset F. Male sex, discoid lupus erythematosus, and lower limb involvement are associated with systemic lupus in lupus panniculitis patients: A multicenter case series of 74 patients. J Am Acad Dermatol 2021; 87:219-221. [PMID: 34352346 DOI: 10.1016/j.jaad.2021.07.052] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2021] [Revised: 07/16/2021] [Accepted: 07/20/2021] [Indexed: 10/20/2022]
Affiliation(s)
- Juliette Lemasson
- Université de Paris, AP-HP, Service de dermatologie, Hôpital Saint-Louis, Paris, France.
| | - Laure Frumholtz
- Université de Paris, AP-HP, Service de dermatologie, Hôpital Saint-Louis, Paris, France
| | - Marie Jachiet
- Université de Paris, AP-HP, Service de dermatologie, Hôpital Saint-Louis, Paris, France
| | - Cédric Lenormand
- Faculté de Médecine, Université de Strasbourg et Clinique Dermatologique, Hôpitaux Universitaires, Strasbourg, France
| | - Dan Lipsker
- Faculté de Médecine, Université de Strasbourg et Clinique Dermatologique, Hôpitaux Universitaires, Strasbourg, France
| | - Sophie Moulin
- Université Côte d'Azur, Dermatologie, CHU de Nice, Nice, France
| | | | | | | | - Florence Cordoliani
- Université de Paris, AP-HP, Service de dermatologie, Hôpital Saint-Louis, Paris, France
| | - Martine Bagot
- Université de Paris, AP-HP, Service de dermatologie, Hôpital Saint-Louis, Paris, France
| | - Jean-Benoît Monfort
- Sorbonne Université, Faculté de Médecine Sorbonne Université, AP-HP, Service de Dermatologie et Allergologie, Hôpital Tenon, Paris, France
| | - Patricia Senet
- Sorbonne Université, Faculté de Médecine Sorbonne Université, AP-HP, Service de Dermatologie et Allergologie, Hôpital Tenon, Paris, France
| | - Adèle De Masson
- Université de Paris, AP-HP, Service de dermatologie, Hôpital Saint-Louis, Paris, France
| | - Charles Cassius
- Université de Paris, AP-HP, Service de dermatologie, Hôpital Saint-Louis, Paris, France
| | - Antoine Petit
- Université de Paris, AP-HP, Service de dermatologie, Hôpital Saint-Louis, Paris, France
| | | | - Philippe Moguelet
- Anatomie et cytologie pathologiques, AP-HP, Hôpital Tenon, Paris, France
| | - Nadège Cordel
- Dermatologie-Immunologie clinique, CHU de la Guadeloupe, Point-à-Pitre, France
| | | | | | - Camille Frances
- Sorbonne Université, Faculté de Médecine Sorbonne Université, AP-HP, Service de Dermatologie et Allergologie, Hôpital Tenon, Paris, France
| | - Didier Bessis
- Dermatologie, CHU de Montpellier, Montpellier, France
| | - Jean-David Bouaziz
- Université de Paris, AP-HP, Service de dermatologie, Hôpital Saint-Louis, Paris, France
| | - François Chasset
- Sorbonne Université, Faculté de Médecine Sorbonne Université, AP-HP, Service de Dermatologie et Allergologie, Hôpital Tenon, Paris, France
| |
Collapse
|
24
|
Delplanque M, Ducharme-Bénard S, Moguelet P, Chasset F, Grateau G, Georgin-Lavialle S, Bachmeyer C. Is neutrophilic dermatosis a manifestation of familial Mediterranean fever? Scand J Rheumatol 2021; 51:42-49. [PMID: 34159892 DOI: 10.1080/03009742.2021.1904588] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
Objectives: Familial Mediterranean fever (FMF) is the most frequent monogenic autoinflammatory disease. It is associated with MEFV mutations. Its main features are recurrent episodes of fever and serositis. Patients can display dermatological manifestations such as erysipelas-like erythema, generally considered as a neutrophilic dermatosis (ND). It has been suggested that FMF can be associated with other types of ND. Our aim was to perform a systematic review of the literature to assess the link between ND and FMF.Method: A systematic review of the literature was performed using MEDLINE from 1946 to 2018. Three independent investigators identified reports of non-erysipelas-like erythema neutrophilic dermatosis (NEND) associated with FMF, selected the criteria to establish the diagnosis of FMF and ND, and evaluated the link between the two conditions. FMF-associated NEND was supported by confirmation of both diagnoses and exclusion of other causes of ND.Results: Eighteen articles were selected. Nine articles reported FMF patients with the following NEND: neutrophilic panniculitis (n = 4), Sweet syndrome (n = 6), and pyoderma gangrenosum (n = 1). None of these cases was supported by histological confirmation, fulfilled diagnostic criteria for definitive or probable FMF, or confirmed the exclusion of all the most frequent diseases associated with NEND. As a result, there is insufficient evidence to support a potential relationship between NEND and FMF.Conclusions: The association between FMF and NEND remains unclear. In FMF patients with NEND, every differential diagnosis and alternative cause of NEND should be excluded before drawing any conclusions about a potential causal relationship.
Collapse
Affiliation(s)
- M Delplanque
- Internal Medicine Department, Reference Centre for Autoinflammatory Diseases and Amyloidosis (CEREMAIA), Tenon Hospital, Paris, France
| | - S Ducharme-Bénard
- Internal Medicine Department, Sacré-Coeur Hospital, Montreal, Canada
| | - P Moguelet
- Anatomopathology Department, Tenon Hospital, Paris, France
| | - F Chasset
- Dermatology Department, Tenon Hospital, Paris, France
| | - G Grateau
- Internal Medicine Department, Reference Centre for Autoinflammatory Diseases and Amyloidosis (CEREMAIA), Tenon Hospital, Paris, France
| | - S Georgin-Lavialle
- Internal Medicine Department, Reference Centre for Autoinflammatory Diseases and Amyloidosis (CEREMAIA), Tenon Hospital, Paris, France
| | - C Bachmeyer
- Internal Medicine Department, Reference Centre for Autoinflammatory Diseases and Amyloidosis (CEREMAIA), Tenon Hospital, Paris, France
| |
Collapse
|
25
|
Martin de Frémont G, Hirsch P, Gimenez De Mestral S, Moguelet P, Ditchi Y, Emile J, Senet P, Georgin-Lavialle S, Hanslik T, Maurier F, Adedjouma A, Abisror N, Mahevas T, Malard F, Ades L, Fenaux P, Fain O, Mekinian A. Infiltrat myéloïde clonal identifié par next generation sequencing dans les lésions cutanées associées aux syndromes myélodysplasiques et leucémies myélomonocytaires chroniques. Rev Med Interne 2021. [DOI: 10.1016/j.revmed.2021.03.253] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
26
|
Hamann P, Moguelet P, Chasset F, Delaleu J, Barbaud A, Senet P, Frances C, De Risi-Pugliese T. Efficacy of tocilizumab in adult H syndrome: a promising therapeutic option. Int J Dermatol 2021; 60:e417-e419. [PMID: 33951194 DOI: 10.1111/ijd.15649] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/05/2021] [Revised: 03/31/2021] [Accepted: 04/14/2021] [Indexed: 12/01/2022]
Affiliation(s)
- Pierre Hamann
- Service de Dermatologie, Institut Gustave Roussy, Université Paris-Saclay, Paris, France
| | - Philippe Moguelet
- Service d'anatomo-pathologie, Hôpital Tenon, AP-HP, Faculté de Médecine, Sorbonne Université, Paris, France
| | - François Chasset
- Service de Dermatologie et Allergologie, Hôpital Tenon, AP-HP, Sorbonne Université, Paris, France
| | - Jeremie Delaleu
- Service de Dermatologie et Allergologie, Hôpital Tenon, AP-HP, Sorbonne Université, Paris, France
| | - Annick Barbaud
- Service de Dermatologie et Allergologie, Hôpital Tenon, AP-HP, Sorbonne Université, Paris, France
| | - Patricia Senet
- Service de Dermatologie et Allergologie, Hôpital Tenon, AP-HP, Sorbonne Université, Paris, France
| | - Camille Frances
- Service de Dermatologie et Allergologie, Hôpital Tenon, AP-HP, Sorbonne Université, Paris, France
| | - Tullia De Risi-Pugliese
- Service de Dermatologie et Allergologie, Hôpital Tenon, AP-HP, Sorbonne Université, Paris, France
| |
Collapse
|
27
|
Compérat E, Moguelet P, Renard-Penna R, Pradere B. [Penile carcinoma: Practical issues, from the biopsy to surgery]. Ann Pathol 2021; 42:5-14. [PMID: 33820662 DOI: 10.1016/j.annpat.2021.03.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2020] [Revised: 03/03/2021] [Accepted: 03/04/2021] [Indexed: 10/21/2022]
Abstract
The management of a penile carcinoma is complex, a collaboration between radiologist, pathologist and urologist is necessary to obtain a correct staging. In this review we try to demonstrate step by step how to achieve a complete pathology report, how to manage the patient (imaging, biopsy, fresh frozen section and surgery).
Collapse
Affiliation(s)
- Eva Compérat
- Service d'anatomie et cytologie pathologiques, Sorbonne université, hôpital Tenon, Paris, France.
| | - Philippe Moguelet
- Service d'anatomie et cytologie pathologiques, Sorbonne université, hôpital Tenon, Paris, France
| | - Raphaele Renard-Penna
- Service de radiologie hôpitaux Tenon et Pitié-Salpêtrière, AP-HP, GRC-UPMC n°5 Oncotype-URO, Sorbonne universités, Paris, France
| | - Benjamin Pradere
- Department of urology, comprehensive cancer center, medical university of Vienna, Vienna, Austria
| |
Collapse
|
28
|
Compérat E, Moguelet P. [Lesions of the penis, the anatomy, epidemiology and carcinogenesis]. Ann Pathol 2021; 42:2-4. [PMID: 33820663 DOI: 10.1016/j.annpat.2021.03.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2020] [Revised: 03/03/2021] [Accepted: 03/04/2021] [Indexed: 11/30/2022]
Abstract
The penile carcinoma is rare, but many items playing a role are complex and it is important to know as well the anatomy, but also the carcinogenesis for a perfect patient's management.
Collapse
Affiliation(s)
- Eva Compérat
- Service d'anatomie et cytologie pathologiques, Sorbonne université, hôpital Tenon, 4, rue de la Chine, 75020 Paris, France.
| | - Philippe Moguelet
- Service d'anatomie et cytologie pathologiques, Sorbonne université, hôpital Tenon, 4, rue de la Chine, 75020 Paris, France
| |
Collapse
|
29
|
Abs D, Landman S, Osio A, Lepesant P, Schneider P, Obadia D, Moguelet P, Farges C, Poirot B, Lehmann-Che J, Lebbé C, Battistella M. Spindle cell tumor with CD34 and S100 co-expression and distinctive stromal and perivascular hyalinization showing EML4-ALK fusion. J Cutan Pathol 2020; 48:896-901. [PMID: 33241586 DOI: 10.1111/cup.13926] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2020] [Revised: 11/11/2020] [Accepted: 11/13/2020] [Indexed: 01/03/2023]
Abstract
Recently, a novel group of CD34+ and S100+ spindle cell tumors with distinctive stromal and perivascular hyalinization showing recurrent gene fusions involving RAF1, BRAF, NTRK1/2/3, and RET has been identified. ALK rearrangements have been rarely reported in this group of tumors. We report a 24-year-old woman with a 1.5-cm pink mass of the scalp. The tumor was made of spindle cells organized in fascicles or haphazardly arranged in a patternless architecture, with areas of stromal and perivascular hyalinization. The tumor cells diffusely expressed CD34 and S100, without SOX-10 expression. The tumor showed diffuse immunopositivity for ALK. RNA sequencing using next-generation sequencing (NGS) detected an EML4-ALK fusion. This case extends the spectrum of this newly described group of CD34+/S100+ spindle cell tumors at the molecular-genetic level. Dermatopathologists should be aware of this recent entity, as it may fall in the differential diagnosis of many other spindle cell tumors with CD34 expression. NGS-based techniques should be performed when facing spindle cell tumors with similar morphology and immunophenotype. Identification of kinase fusions is essential for the precise classification and better knowledge of these tumors, and for targeted therapy in rare aggressive cases.
Collapse
Affiliation(s)
- Diane Abs
- Department of Dermatology, Nancy Regional University Hospital Center, Nancy, France.,Department of Pathology, AP-HP Hôpital Saint-Louis, Paris, France
| | - Samuel Landman
- INSERM U976, HIPI, IRSL, Paris University, Paris, France.,Molecular Oncology Unit, AP-HP Hôpital Saint-Louis, Paris, France
| | - Amélie Osio
- Department of Pathology, AP-HP Hôpital Saint-Louis, Paris, France.,Dermatopathology Laboratory, Centre de Pathologie Cutanée de La Roquette, Paris, France
| | - Pauline Lepesant
- Department of Dermatology, AP-HP Hôpital Saint-Louis, Paris, France
| | - Pierre Schneider
- Department of Dermatology, AP-HP Hôpital Saint-Louis, Paris, France
| | - Déborah Obadia
- Private Plastic Surgery Practice, Cabinet de Chirurgie Plastique, Paris, France
| | - Philippe Moguelet
- Dermatopathology Laboratory, Centre de Pathologie Cutanée de La Roquette, Paris, France
| | - Cécile Farges
- Radiology Center, Centre d'Imagerie Diderot, Paris, France
| | - Brigitte Poirot
- INSERM U976, HIPI, IRSL, Paris University, Paris, France.,Molecular Oncology Unit, AP-HP Hôpital Saint-Louis, Paris, France
| | - Jacqueline Lehmann-Che
- INSERM U976, HIPI, IRSL, Paris University, Paris, France.,Molecular Oncology Unit, AP-HP Hôpital Saint-Louis, Paris, France
| | - Céleste Lebbé
- INSERM U976, HIPI, IRSL, Paris University, Paris, France.,Department of Dermatology, AP-HP Hôpital Saint-Louis, Paris, France
| | - Maxime Battistella
- Department of Pathology, AP-HP Hôpital Saint-Louis, Paris, France.,INSERM U976, HIPI, IRSL, Paris University, Paris, France
| |
Collapse
|
30
|
Lalevée S, Moguelet P, Hurabielle C, Senet P, Pha M, Rivière S, Barbaud A, Amoura Z, Francès C, Chasset F. Cutaneous Kikuchi disease-like inflammatory pattern without lymph node involvement is associated with systemic disease and severe features in lupus erythematous: A case-control study. Lupus 2020; 30:473-477. [PMID: 33292039 DOI: 10.1177/0961203320978519] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
INTRODUCTION Kikuchi-Fujimoto disease (KFD) is a self-limited histiocytic necrotizing lymphadenitis sometimes affecting the skin. "Kikuchi disease-like inflammatory pattern" (KLIP) has been described in cutaneous lesions as similar pathological features in patients without lymph node involvement and as a potential clue for the diagnosis of lupus. We aimed to describe KLIP-associated clinical and immunological features in lupus patients with a retrospective case-control study. METHODS Thirteen cases of KLIP were included as well as thirty-nine age- and sex-matched control lupus patients without KLIP. At the time of KLIP diagnosis, 4/13 patients (31%) had isolated cutaneous lupus erythematosus (CLE) and 9/13 had (69%) systemic lupus erythematosus (SLE) including 6 (46%) with severe haematological, lung, cardiac or renal disease. KLIP features were observed in skin biopsies of different clinical presentations. RESULTS Compared with our control group, KLIP patients more frequently had SLE 9/13 (69%) versus 8/39 (21%) (OR 12.9; IC95% [2.86-58.2]; p = 0.0004) and more frequently severe SLE. Two out of four CLE exhibiting KLIP lesions (50%) developed severe SLE with cardiac or renal involvement after 12 and 24 months, respectively.Treatment with thalidomide 100 mg/day allowed rapid and complete clearance of cutaneous lesions in 6/6 KLIP patients. The need to use thalidomide tended to be more frequent in KLIP patients than in controls. CONCLUSION Our study suggests that KLIP features in lupus skin lesions are associated with SLE and severe systemic features. Despite a limited number of isolated CLE patients with KLIP features in the skin, this observation may warrant closer follow-up on patients with a higher risk of developing SLE.
Collapse
Affiliation(s)
- Sophie Lalevée
- Service d'anatomopathologie, Hôpital Tenon, Assistance Publique-Hôpitaux de Paris, Paris, France
| | - Philippe Moguelet
- Service d'anatomopathologie, Hôpital Tenon, Assistance Publique-Hôpitaux de Paris, Paris, France
| | | | - Patricia Senet
- Sorbonne Université, Medecine, Service de dermatologie et allergologie, APHP, Hôpital Tenon, Paris, France
| | - Micheline Pha
- Service de Medecine Interne 2, Centre National de Reference du lupus systemique, Hôpital Pitie-Salpêtriere, Assistance Publique-Hôpitaux de Paris, Paris, France
| | - Sebastien Rivière
- Sorbonne Université, Faculté de Médecine, AP-HP, Service de Médecine Interne, Hôpital Saint-Antoine, Paris, France
| | - Annick Barbaud
- Sorbonne Université, Medecine, Service de dermatologie et allergologie, APHP, Hôpital Tenon, Paris, France.,INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Médecine Sorbonne Université, Paris, France
| | - Zahir Amoura
- Service de Medecine Interne 2, Centre National de Reference du lupus systemique, Hôpital Pitie-Salpêtriere, Assistance Publique-Hôpitaux de Paris, Paris, France
| | - Camille Francès
- Sorbonne Université, Medecine, Service de dermatologie et allergologie, APHP, Hôpital Tenon, Paris, France
| | - Francois Chasset
- Sorbonne Université, Medecine, Service de dermatologie et allergologie, APHP, Hôpital Tenon, Paris, France
| |
Collapse
|
31
|
Lalevee S, Moguelet P, Hurabielle C, Senet P, Barbaud A, Amoura Z, Frances C, Chasset F. La presentation “Kikuchi disease-like inflammatory pattern (KLIP)” dans la peau des patients atteints de lupus sans atteinte ganglionnaire est associée à des lupus sévères : étude cas-témoins. Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.297] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
32
|
Chasset F, Fayand A, Moguelet P, Kouby F, Bonhomme A, Franck N, Goldman-Lévy G, Fraitag S, Barbaud A, Queyrel V, Touitou I, Boursier G, Sarrabay G, Dupin N, Francès C, Bessis D, Georgin-Lavialle S. Caractéristiques anatomocliniques des atteintes cutanées du déficit en adénosine déaminase 2 : étude de cohorte multicentrique rétrospective et revue systématique de la littérature. Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.451] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
33
|
Lemasson J, Frumholtz L, Lenormand C, Lipsker D, Jachiet M, Moulin S, Chiaverini C, Le Duff F, Passeron T, Cordoliani F, Bagot M, Montfort JB, Senet P, De Masson A, Cassius C, Petit A, Misery L, Moguelet P, Cordel N, Fardet L, Begon E, Frances C, Bessis D, Bouaziz JD, Chasset F. Étude nationale française multicentrique de 74 patients atteints de panniculite lupique. Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.139] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
34
|
Merlant M, Lepelletier C, Battistella M, Vignon-Pennamen MD, Duriez P, Moguelet P, Brunet-Possenti F, Bagot M, Chasset F, Bouaziz JD. Acute myeloid leukemia and myelodysplastic syndrome-associated Sweet syndrome: A comparative multicenter retrospective study of 39 patients. J Am Acad Dermatol 2020; 84:838-840. [PMID: 33065169 DOI: 10.1016/j.jaad.2020.09.089] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/15/2020] [Revised: 08/14/2020] [Accepted: 09/19/2020] [Indexed: 11/20/2022]
Affiliation(s)
- Marie Merlant
- Faculté de Médecine Paris Diderot, Assistance Publique de Hôpitaux de Paris, Service de Dermatologie, Hôpital Saint-Louis, Paris, France.
| | - Clémence Lepelletier
- Faculté de Médecine Paris Diderot, Assistance Publique de Hôpitaux de Paris, Service de Dermatologie, Hôpital Saint-Louis, Paris, France
| | - Maxime Battistella
- Faculté de Médecine Paris Diderot, Assistance Publique de Hôpitaux de Paris, Service de Pathologie, Hôpital Saint-Louis, Paris, France
| | - Marie-Dominique Vignon-Pennamen
- Faculté de Médecine Paris Diderot, Assistance Publique de Hôpitaux de Paris, Service de Pathologie, Hôpital Saint-Louis, Paris, France
| | - Paul Duriez
- Faculté de Médecine Sorbonne Université, Assistance Publique de Hôpitaux de Paris, Service de Pathologie, Hôpital Saint-Antoine, Paris, France
| | - Philippe Moguelet
- Faculté de Médecine Sorbonne Université, Assistance Publique de Hôpitaux de Paris, Pathologie, Hôpital Tenon, Paris, France
| | - Florence Brunet-Possenti
- Faculté de médecine Paris Diderot, Assistance Publique de Hôpitaux de Paris, Service de Dermatologie, Hôpital Bichat, Paris, France
| | - Martine Bagot
- Faculté de Médecine Paris Diderot, Assistance Publique de Hôpitaux de Paris, Service de Dermatologie, Hôpital Saint-Louis, Paris, France
| | - François Chasset
- Faculté de Médecine Sorbonne Université, Assistance Publique de Hôpitaux de Paris, Service de Dermatologie et Allergologie, Hôpital Tenon, Paris, France
| | - Jean David Bouaziz
- Faculté de Médecine Paris Diderot, Assistance Publique de Hôpitaux de Paris, Service de Dermatologie, Hôpital Saint-Louis, Paris, France
| |
Collapse
|
35
|
Aitmehdi R, Moguelet P, Godot S, Chazerain P, Senet P, Barbaud A, Frances C, Chasset F. Response to rituximab of pseudotumoral digital nodules in a patient with granulomatosis with polyangiitis with alpha‐1 antitrypsin deficiency: A case report. Dermatol Ther 2020; 33:e13479. [DOI: 10.1111/dth.13479] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/17/2020] [Revised: 04/07/2020] [Accepted: 04/23/2020] [Indexed: 11/28/2022]
Affiliation(s)
- Raphaël Aitmehdi
- Faculté de Médecine Sorbonne Université AP‐HP, Service de Dermatologie et Allergologie, Hôpital Tenon Paris France
| | - Philippe Moguelet
- Faculté de Médecine Sorbonne Université AP‐HP, Service de Pathologie, Hôpital Tenon Paris France
| | - Sophie Godot
- Service de Rhumatologie Groupe Hospitalier Diaconnesses Croix Saint Simon Paris France
| | - Pascal Chazerain
- Service de Rhumatologie Groupe Hospitalier Diaconnesses Croix Saint Simon Paris France
| | - Patricia Senet
- Faculté de Médecine Sorbonne Université AP‐HP, Service de Dermatologie et Allergologie, Hôpital Tenon Paris France
| | - Annick Barbaud
- Faculté de Médecine Sorbonne Université AP‐HP, Service de Dermatologie et Allergologie, Hôpital Tenon Paris France
| | - Camille Frances
- Faculté de Médecine Sorbonne Université AP‐HP, Service de Dermatologie et Allergologie, Hôpital Tenon Paris France
| | - François Chasset
- Faculté de Médecine Sorbonne Université AP‐HP, Service de Dermatologie et Allergologie, Hôpital Tenon Paris France
| |
Collapse
|
36
|
Colboc H, Moguelet P, Bazin D, Carvalho P, Dillies AS, Chaby G, Maillard H, Kottler D, Goujon E, Jurus C, Panaye M, Frochot V, Letavernier E, Daudon M, Lucas I, Weil R, Courville P, Monfort JB, Chasset F, Senet P. Localization, Morphologic Features, and Chemical Composition of Calciphylaxis-Related Skin Deposits in Patients With Calcific Uremic Arteriolopathy. JAMA Dermatol 2020; 155:789-796. [PMID: 31116362 DOI: 10.1001/jamadermatol.2019.0381] [Citation(s) in RCA: 18] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
Abstract
Importance Calcific uremic arteriolopathy (CUA), a rare, potentially fatal, disease with calcium deposits in skin, mostly affects patients with end-stage renal disease who are receiving dialysis. Chemical composition and structure of CUA calcifications have been poorly described. Objectives To describe the localization and morphologic features and determine the precise chemical composition of CUA-related calcium deposits in skin, and identify any mortality-associated factors. Design, Setting, and Participants A retrospective, multicenter cohort study was conducted at 7 French hospitals including consecutive adults diagnosed with CUA between January 1, 2006, and January 1, 2017, confirmed according to Hayashi clinical and histologic criteria. Patients with normal renal function were excluded. For comparison, 5 skin samples from patients with arteriolosclerosis and 5 others from the negative margins of skin-carcinoma resection specimens were also analyzed. Main Outcomes and Measures Localization and morphologic features of the CUA-related cutaneous calcium deposits were assessed with optical microscopy and field-emission-scanning electron microscopy, and the chemical compositions of those deposits were evaluated with μ Fourier transform infrared spectroscopy, Raman spectroscopy, and energy dispersive radiographs. Results Thirty-six patients (median [range] age, 64 [33-89] years; 26 [72%] female) were included, and 29 cutaneous biopsies were analyzed. Calcific uremic arteriolopathy and arteriolosclerosis skin calcifications were composed of pure calcium-phosphate apatite. Calcific uremic arteriolopathy vascular calcifications were always circumferential, found in small to medium-sized vessels, with interstitial deposits in 22 (76%) of the samples. A thrombosis, most often in noncalcified capillary lumens in the superficial dermis, was seen in 5 samples from patients with CUA. Except for calcium deposits, the vessel structure of patients with CUA appeared normal, unlike thickened arteriolosclerotic vessel walls. Twelve (33%) patients died of CUA. Conclusions and Relevance Calcific uremic arteriolopathy-related skin calcifications were exclusively composed of pure calcium-phosphate apatite, localized circumferentially in small to medium-sized vessels and often associated with interstitial deposits, suggesting its pathogenesis differs from that of arteriolosclerosis. Although the chemical compositions of CUA and arteriolosclerosis calcifications were similar, the vessels' appearances and deposit localizations differed, suggesting different pathogenetic mechanisms.
Collapse
Affiliation(s)
- Hester Colboc
- Service Plaies et Cicatrisation, Sorbonne Université, Hôpital Rothschild, Paris, France.,Institut National de la Santé et de la Recherche Médicale (INSERM), Unité Mixte de Recherche (UMR) S 1155, Paris, France
| | - Philippe Moguelet
- Anatomie et Cytologie Pathologiques, Sorbonne Université, Hôpital Tenon, Paris, France
| | - Dominique Bazin
- Centre National de la Recherche Scientifique (CNRS), Laboratoire de Chimie Physique, Ba340, Université Paris XI, Orsay, France
| | - Priscille Carvalho
- Service de Dermatologie, Centre Hospitalier Universitaire de Rouen, Rouen, France
| | - Anne-Sophie Dillies
- Service de Dermatologie, Centre Hospitalier Universitaire d'Amiens, Amiens, France
| | - Guillaume Chaby
- Service de Dermatologie, Centre Hospitalier Universitaire d'Amiens, Amiens, France
| | - Hervé Maillard
- Service de Dermatologie, Centre Hospitalier du Mans, Le Mans, France
| | - Diane Kottler
- Service de Dermatologie, Hôpital Bichat, Paris, France
| | - Elisa Goujon
- Service de Dermatologie, Centre Hospitalier de Chalon-sur-Saône, Chalon-sur-Saône, France
| | - Christine Jurus
- Service de Médecine Vasculaire, Clinique du Tonkin, Villeurbanne, France
| | - Marine Panaye
- Service de Médecine Vasculaire, Clinique du Tonkin, Villeurbanne, France
| | - Vincent Frochot
- Service des Explorations Fonctionnelles Multidisciplinaires, Sorbonne Université, Hôpital Tenon, Paris, France
| | - Emmanuel Letavernier
- Institut National de la Santé et de la Recherche Médicale (INSERM), Unité Mixte de Recherche (UMR) S 1155, Paris, France.,Sorbonne Université, Hôpital Tenon, Service des Explorations Fonctionnelles Multidisciplinaires, Paris
| | - Michel Daudon
- Service des Explorations Fonctionnelles Multidisciplinaires, Sorbonne Université, Hôpital Tenon, Paris, France
| | - Ivan Lucas
- Sorbonne Universités, Unité Mixte de Recherche (UMR) 8235, Paris, France
| | - Raphaël Weil
- Centre National de la Recherche Scientifique (CNRS), Laboratoire de Physique des Solides, Ba510, Université Paris XI, Orsay, France
| | - Philippe Courville
- Centre Hospitalier Universitaire de Rouen, Anatomie et Cytologie Pathologiques, Rouen, France
| | | | - François Chasset
- Service de Dermatologie, Sorbonne Université, Hôpital Tenon, Paris, France
| | - Patricia Senet
- Service de Dermatologie, Sorbonne Université, Hôpital Tenon, Paris, France
| | | |
Collapse
|
37
|
de Risi-Pugliese T, Barailler H, Hamelin A, Amsler E, Gaouar H, Kurihara F, Jullie ML, Merrill ED, Barbaud A, Moguelet P, Milpied-Homsi B, Soria A. Symmetrical drug-related intertriginous and flexural exanthema: A little-known drug allergy. J Allergy Clin Immunol Pract 2020; 8:3185-3189.e4. [PMID: 32376489 DOI: 10.1016/j.jaip.2020.04.052] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/23/2019] [Revised: 04/08/2020] [Accepted: 04/21/2020] [Indexed: 12/20/2022]
Affiliation(s)
- Tullia de Risi-Pugliese
- AP-HP, Service de Dermatologie et Allergologie, Hôpital Tenon, Paris, France; Sorbonne Université, UPMC University, Paris, France.
| | | | - Aurore Hamelin
- AP-HP, Service de Dermatologie et Allergologie, Hôpital Tenon, Paris, France
| | - Emmanuelle Amsler
- AP-HP, Service de Dermatologie et Allergologie, Hôpital Tenon, Paris, France; Sorbonne Université, UPMC University, Paris, France
| | - Hafida Gaouar
- AP-HP, Service de Dermatologie et Allergologie, Hôpital Tenon, Paris, France
| | - Flore Kurihara
- AP-HP, Service de Dermatologie et Allergologie, Hôpital Tenon, Paris, France; Sorbonne Université, UPMC University, Paris, France
| | | | - Eric Dean Merrill
- Department of Dermatology, University of California San Francisco, San Francisco, Calif
| | - Annick Barbaud
- AP-HP, Service de Dermatologie et Allergologie, Hôpital Tenon, Paris, France; Sorbonne Université, UPMC University, Paris, France
| | | | | | - Angèle Soria
- AP-HP, Service de Dermatologie et Allergologie, Hôpital Tenon, Paris, France; Sorbonne Université, UPMC University, Paris, France; Inserm 1135, Centre d'Immunologie et des Maladies Infectieuses (Cimi-Paris), Paris, France
| |
Collapse
|
38
|
Brehon A, Moguelet P, Guégan S, Abisror N, Barbaud A, Beal C, Laffitte E, Fain O, Francès C, Chasset F. Discoid drug‐induced lupus erythematosus induced by antitumor necrosis factor agents is a very rare subtype of cutaneous lupus: Three cases and literature review. Dermatol Ther 2020; 33:e13364. [DOI: 10.1111/dth.13364] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2019] [Revised: 03/06/2020] [Accepted: 03/28/2020] [Indexed: 11/30/2022]
Affiliation(s)
- Alice Brehon
- Faculté de Médecine Sorbonne Université, AP‐HP, Service de Dermatologie et Allergologie, Hôpital Tenon Paris France
| | - Philippe Moguelet
- Faculté de Médecine Sorbonne Université, AP‐HP, Service de Pathologie, Hôpital Tenon Paris France
| | - Sarah Guégan
- Faculté de Médecine Paris Descartes AP‐HP, Service de Dermatologie, Hôpital Cochin Paris France
| | - Noémie Abisror
- Faculté de Médecine Sorbonne Université, AP‐HP, Service de Médecine Interne, Hôpital Saint‐Antoine Paris France
| | - Annick Barbaud
- Faculté de Médecine Sorbonne Université, AP‐HP, Service de Dermatologie et Allergologie, Hôpital Tenon Paris France
| | - Caroline Beal
- Service de Médecine Interne‐Rhumatologie, Groupe Hospitalier Diaconesses Croix Saint‐Simon Paris France
| | - Emmanuel Laffitte
- Service de Dermatologie, Hôpitaux Universitaires de Genève Genève Switzerland
| | - Olivier Fain
- Faculté de Médecine Sorbonne Université, AP‐HP, Service de Médecine Interne, Hôpital Saint‐Antoine Paris France
| | - Camille Francès
- Faculté de Médecine Sorbonne Université, AP‐HP, Service de Dermatologie et Allergologie, Hôpital Tenon Paris France
| | - François Chasset
- Faculté de Médecine Sorbonne Université, AP‐HP, Service de Dermatologie et Allergologie, Hôpital Tenon Paris France
| |
Collapse
|
39
|
Delaleu J, Grynberg-Laloum E, Moguelet P, Hamann P, Francès C, Barbaud A, Senet P. Prurigo pigmentosa induced by ketosis ("keto rash"): a demonstrative case and internet search results. Int J Dermatol 2020; 59:876-877. [PMID: 32297975 DOI: 10.1111/ijd.14873] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/19/2020] [Revised: 03/11/2020] [Accepted: 03/20/2020] [Indexed: 11/30/2022]
Affiliation(s)
- Jérémie Delaleu
- Department of Dermatology, Tenon Hospital, APHP, Paris, France.,Sorbonne Univsersité, Paris, France
| | | | - Philippe Moguelet
- Sorbonne Univsersité, Paris, France.,Laboratory of Pathology, Tenon Hospital, APHP, Paris, France
| | - Pierre Hamann
- Department of Dermatology, Tenon Hospital, APHP, Paris, France.,Sorbonne Univsersité, Paris, France
| | - Camille Francès
- Department of Dermatology, Tenon Hospital, APHP, Paris, France.,Sorbonne Univsersité, Paris, France
| | - Annick Barbaud
- Department of Dermatology, Tenon Hospital, APHP, Paris, France.,Sorbonne Univsersité, Paris, France
| | - Patricia Senet
- Department of Dermatology, Tenon Hospital, APHP, Paris, France.,Sorbonne Univsersité, Paris, France
| |
Collapse
|
40
|
Chasset F, Fayand A, Moguelet P, Kouby F, Bonhomme A, Franck N, Goldman-Lévy G, Fraitag S, Barbaud A, Queyrel V, Touitou I, Boursier G, Sarrabay G, Ducharme-Benard S, Dupin N, Francès C, Bessis D, Georgin-Lavialle S. Clinical and pathological dermatological features of deficiency of adenosine deaminase 2: A multicenter, retrospective, observational study. J Am Acad Dermatol 2020; 83:1794-1798. [PMID: 32283244 DOI: 10.1016/j.jaad.2020.03.110] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2019] [Revised: 03/02/2020] [Accepted: 03/30/2020] [Indexed: 10/24/2022]
Affiliation(s)
- François Chasset
- Sorbonne Université, Faculté de Médecine, Assistance Publique-Hôpitaux de Paris, Service de Dermatologie et Allergologie, Hôpital Tenon, Paris, France.
| | - Antoine Fayand
- Sorbonne Université, Faculté de Médecine, Assistance Publique-Hôpitaux de Paris, Hôpital Tenon, Service de médecine interne, Centre de référence des maladies auto-inflammatoires et des amyloses d'origine inflammatoire (CEREMAIA), Paris, France
| | - Philippe Moguelet
- Sorbonne Université, Faculté de Médecine Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Service d'anatomo-pathologie, Hôpital Tenon, Paris, France
| | - Floriane Kouby
- Sorbonne Université, Faculté de Médecine, Assistance Publique-Hôpitaux de Paris, Service de Dermatologie et Allergologie, Hôpital Tenon, Paris, France
| | - Axelle Bonhomme
- Metz-Thionville Regional Hospital, Dermatology Department, Metz, France
| | - Nathalie Franck
- Université Paris Descartes, Assistance Publique-Hôpitaux de Paris, Service de dermatologie, Hôpital Cochin, Paris, France
| | - Gabrielle Goldman-Lévy
- Université Paris Descartes, Assistance Publique-Hôpitaux de Paris, Service d'anatomo-pathologie, Hôpital Cochin, Paris, France
| | - Sylvie Fraitag
- Assistance Publique-Hôpitaux de Paris, Hôpital Necker-Enfants-Malades, Department of Pathology, Paris, France
| | - Annick Barbaud
- Sorbonne Université, Faculté de Médecine, Assistance Publique-Hôpitaux de Paris, Service de Dermatologie et Allergologie, Hôpital Tenon, Paris, France
| | - Viviane Queyrel
- Centre hospitalo-universitaire Nice, L'Archet hospital, Nice, France
| | - Isabelle Touitou
- Centre hospitalo-universitaire Montpellier, Université Montpellier, Laboratory of Rare and Autoinflammatory Genetic Diseases and CEREMAIA, Montpellier, France
| | - Guilaine Boursier
- Centre hospitalo-universitaire Montpellier, Université Montpellier, Laboratory of Rare and Autoinflammatory Genetic Diseases and CEREMAIA, Montpellier, France
| | - Guillaume Sarrabay
- Centre hospitalo-universitaire Montpellier, Université Montpellier, Laboratory of Rare and Autoinflammatory Genetic Diseases and CEREMAIA, Montpellier, France
| | - Stéphanie Ducharme-Benard
- Sorbonne Université, Faculté de Médecine, Assistance Publique-Hôpitaux de Paris, Hôpital Tenon, Service de médecine interne, Centre de référence des maladies auto-inflammatoires et des amyloses d'origine inflammatoire (CEREMAIA), Paris, France; Service de Médecine Interne, Hôpital du Sacré-Cœur de Montréal, Montréal, Québec, Canada
| | - Nicolas Dupin
- Université Paris Descartes, Assistance Publique-Hôpitaux de Paris, Service de dermatologie, Hôpital Cochin, Paris, France
| | - Camille Francès
- Sorbonne Université, Faculté de Médecine, Assistance Publique-Hôpitaux de Paris, Service de Dermatologie et Allergologie, Hôpital Tenon, Paris, France
| | - Didier Bessis
- Department of Dermatology, Saint-Eloi Hospital and Montpellier University Hospital, Montpellier, France
| | - Sophie Georgin-Lavialle
- Sorbonne Université, Faculté de Médecine, Assistance Publique-Hôpitaux de Paris, Hôpital Tenon, Service de médecine interne, Centre de référence des maladies auto-inflammatoires et des amyloses d'origine inflammatoire (CEREMAIA), Paris, France
| | | |
Collapse
|
41
|
Colboc H, Bazin D, Moguelet P, Reguer S, Amode R, Jouanneau C, Lucas I, Deschamps L, Descamps V, Kluger N. Chemical composition and distribution of tattoo inks within tattoo-associated keratoacanthoma. J Eur Acad Dermatol Venereol 2020; 34:e313-e315. [PMID: 31960997 DOI: 10.1111/jdv.16220] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Affiliation(s)
- H Colboc
- Wound Healing Department, Rothschild Hospital, Sorbonne Université, Paris, France
| | - D Bazin
- CNRS, LCP, Ba340, Paris XI University, Orsay, France
| | - P Moguelet
- Department of Pathology, Tenon Hospital, Sorbonne Université, Paris, France
| | - S Reguer
- DiffAbs beamline, Synchrotron SOLEIL L'Orme des Merisiers Saint-Aubin, Synchrotron Soleil, Gif-sur-Yvette Cedex, France
| | - R Amode
- «Tattoo» Consultation, Department of Dermatology, Bichat-Claude Bernard Hospital, HUPNVS, Paris, France
| | - C Jouanneau
- UMRS 1155, Tenon Hospital, Sorbonne Université, Paris, France
| | - I Lucas
- UMR 8235, Sorbonne Université, Paris, France
| | - L Deschamps
- Department of Pathology, Bichat-Claude Bernard Hospital, HUPNVS, Paris, France
| | - V Descamps
- «Tattoo» Consultation, Department of Dermatology, Bichat-Claude Bernard Hospital, HUPNVS, Paris, France
| | - N Kluger
- «Tattoo» Consultation, Department of Dermatology, Bichat-Claude Bernard Hospital, HUPNVS, Paris, France.,Department of Dermatology, Allergology and Venereology, Helsinki University Hospital, Helsinki, Finland
| |
Collapse
|
42
|
Galezowski A, Delyon J, Le Cleach L, Guégan S, Ducroux E, Alanio A, Lastennet D, Moguelet P, Dadban A, Leccia MT, Le Pelletier F, Francès C, Lebbé C, Barete S. Deep cutaneous fungal infections in solid-organ transplant recipients. J Am Acad Dermatol 2020; 83:455-462. [PMID: 31931081 DOI: 10.1016/j.jaad.2019.12.064] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2019] [Revised: 12/23/2019] [Accepted: 12/31/2019] [Indexed: 01/18/2023]
Abstract
BACKGROUND Deep cutaneous fungal infections (DCFIs) are varied in immunosuppressed patients, with few data for such infections in solid-organ transplant recipients (s-OTRs). OBJECTIVE To determine DCFI diagnostic characteristics and outcome with treatments in s-OTRs. METHODS A 20-year retrospective observational study in France was conducted in 8 primary dermatology-dedicated centers for s-OTRs diagnosed with DCFIs. Relevant clinical data on transplants, fungal species, treatments, and outcomes were analyzed. RESULTS Overall, 46 s-OTRs developed DCFIs (median delay, 13 months after transplant) with predominant phaeohyphomycoses (46%). Distribution of nodular lesions on limbs and granulomatous findings on histopathology were helpful diagnostic clues. Treatments received were systemic antifungal therapies (48%), systemic antifungal therapies combined with surgery (28%), surgery alone (15%), and modulation of immunosuppression (61%), leading to complete response in 63% of s-OTRs. LIMITATIONS Due to the retrospective observational design of the study. CONCLUSIONS Phaeohyphomycoses are the most common DCFIs in s-OTRs. Multidisciplinary teams are helpful for optimal diagnosis and management.
Collapse
Affiliation(s)
- Agnès Galezowski
- Unit of Dermatology, DMU3ID, Pitié-Salpêtrière Hospital, AP-HP, Sorbonne University, Paris, France
| | - Julie Delyon
- Department of Dermatology, Saint-Louis Hospital, AP-HP, Institut National de la Santé et de la Recherche Médicale U976, Université de Paris Paris, France
| | - Laurence Le Cleach
- Department of Dermatology, Henri Mondor Hospital, AP-HP, Paris-Est Créteil Val de Marne-Paris 12 University, Créteil, France
| | - Sarah Guégan
- Department of Dermatology, Cochin Hospital, AP-HP, Paris Descartes University, Paris, France
| | - Emilie Ducroux
- Department of Dermatology, Edouard Herriot Hospital, Lyon, France
| | - Alexandre Alanio
- Department of Parasitology-Mycology, Saint-Louis Hospital, AP-HP, Université de Paris Paris, France; Unit of Molecular Mycology, Centre National de la Recherche Scientifique Unité Mixte de Recherche 2000, Institut Pasteur, Paris, France
| | - Diane Lastennet
- Unit of Public Health, Department of Biostatistics, Pitié-Salpêtrière Hospital, AP-HP, Sorbonne University, Paris, France
| | | | - Ali Dadban
- Department of Dermatology, Amiens University Hospital, Amiens, France
| | | | | | - Camille Francès
- Department of Dermatology, DMU3ID, Tenon Hospital, AP-HP, Paris, France
| | - Céleste Lebbé
- Department of Dermatology, Saint-Louis Hospital, AP-HP, Institut National de la Santé et de la Recherche Médicale U976, Université de Paris Paris, France
| | - Stéphane Barete
- Unit of Dermatology, DMU3ID, Pitié-Salpêtrière Hospital, AP-HP, Sorbonne University, Paris, France.
| | | |
Collapse
|
43
|
Rousset L, Moguelet P, Hamann P, Senet P, Bachmeyer C, Lionnet F. Cinq cas de crise vaso-occlusive bulleuse drépanocytaire. Ann Dermatol Venereol 2019. [DOI: 10.1016/j.annder.2019.09.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
44
|
Merlant M, Lepelletier C, Battistella M, Vignon-Pennamen MD, Duriez P, Moguelet P, Brunet-Possenti F, Deschamps L, Bagot M, Chasset F, Bouaziz JD. Étude comparative des syndromes de Sweet associés aux syndromes myélodysplasiques et aux leucémies aiguës myéloïdes : cohorte rétrospective de 39 patients. Ann Dermatol Venereol 2019. [DOI: 10.1016/j.annder.2019.09.062] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
45
|
Sonigo G, Battistella M, Beylot-Barry M, Oro S, Franck N, Barete S, Boulinguez S, Dereure O, Bonnet N, Socié G, Brice P, Boccara O, Bodemer C, Adamski H, D’Incan M, Ortonne N, Fraitag S, Brunet-Possenti F, Dalle S, Suarez F, Marcais A, Skowron F, Haidar D, Maubec E, Bohelay G, Laroche L, Mahé A, Birckel E, Bouaziz JD, Brocheriou I, Dubois R, Faiz S, Fadlallah J, Ram-Wolff C, Carlotti A, Bens G, Balme B, Vergier B, Laurent-Roussel S, Deschamps L, Carpentier O, Moguelet P, Hervé G, Comoz F, Le Gall F, Leverger G, Finon A, Augereau O, Bléchet C, Kerdraon R, lamant L, Tournier E, Franck F, Costes-Martineau V, Szablewski V, Taix S, Beschet I, Guérin F, Sepulveda F, Bagot M, De Saint-Basile G, Michonneau D, De Masson A. Étude clinique à long terme et mutations HAVCR2 chez 70 patients atteints de lymphome T sous cutané à type de panniculite. Ann Dermatol Venereol 2019. [DOI: 10.1016/j.annder.2019.09.144] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
46
|
Colboc H, Moguelet P, Bazin D, Lucas I, Reguer S, Frochot V, Deschamps L, Descamps V, Kluger N. Kératoacanthomes développés sur tatouages : détection et caractérisation des composés organiques. Ann Dermatol Venereol 2019. [DOI: 10.1016/j.annder.2019.09.236] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
47
|
Assrawi E, Louvrier C, Lepelletier C, Georgin-Lavialle S, Bouaziz JD, Awad F, Moinet F, Moguelet P, Vignon-Pennamen MD, Piterboth W, Jumeau C, Cobret L, El Khouri E, Copin B, Duquesnoy P, Legendre M, Grateau G, Karabina SA, Amselem S, Giurgea I. Somatic Mosaic NLRP3 Mutations and Inflammasome Activation in Late-Onset Chronic Urticaria. J Invest Dermatol 2019; 140:791-798.e2. [PMID: 31513803 DOI: 10.1016/j.jid.2019.06.153] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/05/2019] [Revised: 06/26/2019] [Accepted: 06/27/2019] [Indexed: 01/20/2023]
Abstract
Chronic urticaria is a common skin disorder with heterogeneous causes. In the absence of physical triggers, chronic urticarial rash is called idiopathic or spontaneous. The objective of this study was to identify the molecular and cellular bases of a disease condition displayed by two unrelated patients aged over 60 years who presented for two decades with a chronic urticaria resistant to standard therapy that occurred in the context of systemic inflammation not triggered by cold. In both patients, a targeted sequencing approach using a next generation technology identified somatic mosaic mutations in NLRP3, a gene encoding a key inflammasome component. The study of several of both patients' cell types showed that, despite the late onset of the disease, NLRP3 mutations were not found to be restricted to myelomonocytic cells. Rather, the data obtained strongly suggested that the mutational event occurred very early, during embryonic development. As shown by functional studies, the identified mutations-an in-frame deletion and a recurrent NLRP3 missense mutation-have a gain-of-function effect on NLRP3-inflammasome activation. Consistently, a complete remission was obtained in both patients with anti-IL-1 receptor antagonists. This study unveils that in late-onset chronic urticaria, the search for autoinflammatory markers and somatic mosaic NLRP3 mutations may have important diagnostic and therapeutic consequences.
Collapse
Affiliation(s)
- Eman Assrawi
- Sorbonne Université, INSERM, Hôpital Trousseau, Maladies génétiques d'expression pédiatrique, Paris, France
| | - Camille Louvrier
- Sorbonne Université, INSERM, Hôpital Trousseau, Maladies génétiques d'expression pédiatrique, Paris, France; Unité Fonctionnelle de génétique moléculaire, Assistance Publique-Hôpitaux de Paris, Hôpital Trousseau, Paris, France
| | - Clémence Lepelletier
- Service de dermatologie, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Paris, France
| | - Sophie Georgin-Lavialle
- Sorbonne Université, INSERM, Hôpital Trousseau, Maladies génétiques d'expression pédiatrique, Paris, France; Service de médecine interne, Assistance Publique-Hôpitaux de Paris, Hôpital Tenon, Paris, France
| | - Jean-David Bouaziz
- Service de dermatologie, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Paris, France
| | - Fawaz Awad
- Sorbonne Université, INSERM, Hôpital Trousseau, Maladies génétiques d'expression pédiatrique, Paris, France; Current address: Al-Quds University, Faculty of Medicine, Biochemistry and Molecular Biology Department, Abu Deis, Jerusalem, Palestine
| | - Florence Moinet
- Service de médecine interne, Centre Hospitalier Universitaire de Martinique, Martinique, Fort de France, France
| | - Philippe Moguelet
- Unité d'anatomie et cytologie pathologiques, Assistance Publique-Hôpitaux de Paris, Hôpital Tenon, Paris, France
| | | | - William Piterboth
- Unité Fonctionnelle de génétique moléculaire, Assistance Publique-Hôpitaux de Paris, Hôpital Trousseau, Paris, France
| | - Claire Jumeau
- Sorbonne Université, INSERM, Hôpital Trousseau, Maladies génétiques d'expression pédiatrique, Paris, France
| | - Laetitia Cobret
- Sorbonne Université, INSERM, Hôpital Trousseau, Maladies génétiques d'expression pédiatrique, Paris, France
| | - Elma El Khouri
- Sorbonne Université, INSERM, Hôpital Trousseau, Maladies génétiques d'expression pédiatrique, Paris, France
| | - Bruno Copin
- Unité Fonctionnelle de génétique moléculaire, Assistance Publique-Hôpitaux de Paris, Hôpital Trousseau, Paris, France
| | - Philippe Duquesnoy
- Sorbonne Université, INSERM, Hôpital Trousseau, Maladies génétiques d'expression pédiatrique, Paris, France
| | - Marie Legendre
- Sorbonne Université, INSERM, Hôpital Trousseau, Maladies génétiques d'expression pédiatrique, Paris, France; Unité Fonctionnelle de génétique moléculaire, Assistance Publique-Hôpitaux de Paris, Hôpital Trousseau, Paris, France
| | - Gilles Grateau
- Sorbonne Université, INSERM, Hôpital Trousseau, Maladies génétiques d'expression pédiatrique, Paris, France; Service de médecine interne, Assistance Publique-Hôpitaux de Paris, Hôpital Tenon, Paris, France
| | - Sonia A Karabina
- Sorbonne Université, INSERM, Hôpital Trousseau, Maladies génétiques d'expression pédiatrique, Paris, France
| | - Serge Amselem
- Sorbonne Université, INSERM, Hôpital Trousseau, Maladies génétiques d'expression pédiatrique, Paris, France; Unité Fonctionnelle de génétique moléculaire, Assistance Publique-Hôpitaux de Paris, Hôpital Trousseau, Paris, France.
| | - Irina Giurgea
- Sorbonne Université, INSERM, Hôpital Trousseau, Maladies génétiques d'expression pédiatrique, Paris, France; Unité Fonctionnelle de génétique moléculaire, Assistance Publique-Hôpitaux de Paris, Hôpital Trousseau, Paris, France.
| |
Collapse
|
48
|
Rouillé T, Aractingi S, Kadlub N, Fraitag S, How-Kit A, Moguelet P, Picard A, Fontaine R, Guégan S. 530 Local inhibition of MEK/AKT prevents cellular growth in human congenital melanocytic nevi. J Invest Dermatol 2019. [DOI: 10.1016/j.jid.2019.07.445] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
49
|
Bonnet P, Chasset F, Moguelet P, Abisror N, Itzykson R, Bouaziz JD, Hirsch P, Barbaud A, Haroche J, Mekinian A, Hélias-Rodzewicz Z, Clappier E, Fenaux P, Fain O, Tazi A, Emile JF. Erdheim-Chester disease associated with chronic myelomonocytic leukemia harboring the same clonal mutation. Haematologica 2019; 104:e530-e533. [PMID: 31221777 DOI: 10.3324/haematol.2019.223552] [Citation(s) in RCA: 17] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Affiliation(s)
- Pauline Bonnet
- Faculté de Médecine Sorbonne Université, AP-HP, Service de Dermatologie et Allergologie, Hôpital Tenon, Paris
| | - François Chasset
- Faculté de Médecine Sorbonne Université, AP-HP, Service de Dermatologie et Allergologie, Hôpital Tenon, Paris
| | - Philippe Moguelet
- Faculté de Médecine Sorbonne Université, AP-HP, Service de Pathologie, Hôpital Tenon, Paris
| | - Noémie Abisror
- Faculté de Médecine Sorbonne Université, AP-HP, Service de Médecine Interne, Hôpital Saint-Antoine, Paris
| | - Raphaël Itzykson
- Faculté de Médecine Paris Diderot, AP-HP, Service d'Hématologie, Hôpital Saint-Louis, Paris
| | - Jean-David Bouaziz
- Faculté de Médecine Paris Diderot, AP-HP, Service de Dermatologie, Hôpital Saint-Louis, Paris
| | - Pierre Hirsch
- Faculté de Médecine Sorbonne Université, AP-HP, Service de Biologie Cellulaire, Hôpital Saint-Antoine, Paris
| | - Annick Barbaud
- Faculté de Médecine Sorbonne Université, AP-HP, Service de Dermatologie et Allergologie, Hôpital Tenon, Paris
| | - Julien Haroche
- Faculté de Médecine Sorbonne Université, AP-HP, Service de Médecine Interne 2, Hôpital Pitié-Salpêtrière, Paris
| | - Arsène Mekinian
- Faculté de Médecine Sorbonne Université, AP-HP, Service de Médecine Interne, Hôpital Saint-Antoine, Paris
| | - Zofia Hélias-Rodzewicz
- Faculté de Médecine Université de Versailles, AP-HP, Service de Pathologie et laboratoire EA4340, Hôpital Ambroise Paré, Boulogne
| | - Emmanuelle Clappier
- Faculté de Médecine Paris Diderot, AP-HP, laboratoire Génome et Cancer, INSERM UMR944 et CNRS UMR7212, Hôpital Saint-Louis, Paris
| | - Pierre Fenaux
- Faculté de Médecine Paris Diderot, AP-HP, Service d'Hématologie, Hôpital Saint-Louis, Paris
| | - Olivier Fain
- Faculté de Médecine Sorbonne Université, AP-HP, Service de Médecine Interne, Hôpital Saint-Antoine, Paris
| | - Abdellatif Tazi
- Faculté de Médecine Paris Diderot, AP-HP, Service de Pneumologie, Hôpital Saint-Louis, Paris, France
| | - Jean-François Emile
- Faculté de Médecine Université de Versailles, AP-HP, Service de Pathologie et laboratoire EA4340, Hôpital Ambroise Paré, Boulogne
| | | |
Collapse
|
50
|
Poirier E, Fraitag S, Tezenas du Montcel S, Moguelet P, Charlotte F, Lortholary O, Hermine O, Canioni D, Barete S. CD30 expression in cutaneous lesions of systemic mastocytosis: clinical, biological and histopathological analysis of 27 patients. J Eur Acad Dermatol Venereol 2019; 33:e344-e347. [DOI: 10.1111/jdv.15633] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Affiliation(s)
- E. Poirier
- Unité Fonctionnelle de Dermatologie Groupe Hospitalier Pitié‐Salpêtrière, AP‐HP UPMC Université Paris 06 Sorbonne Université Paris France
| | - S. Fraitag
- Centre National de Référence des Mastocytoses AP‐HP CEREMAST Paris France
- Service d'Anatomopathologie Hôpital Necker AP‐HP Université Paris‐Sorbonne Paris France
| | - S. Tezenas du Montcel
- UMR S 1136, INSERM U 1136 Institut Pierre Louis d’Épidémiologie et de Santé Publique UPMC Université Paris 06 Sorbonne Université Paris France
- Unité de Biostatistiques Groupe Hospitalier Pitié‐Salpêtrière AP‐HP Paris France
| | - P. Moguelet
- Service d'Anatomopathologie Hôpital Tenon, AP‐HP UPMC Université Paris 06 Sorbonne Universités Paris France
| | - F. Charlotte
- Service d'Anatomopathologie Groupe Hospitalier Pitié Salpêtrière, AP‐HP UPMC Université Paris 06 Sorbonne Université Paris France
| | - O. Lortholary
- Centre National de Référence des Mastocytoses AP‐HP CEREMAST Paris France
- Service d'Infectiologie Hôpital Necker AP‐HP Université Paris‐Sorbonne Paris France
| | - O. Hermine
- Centre National de Référence des Mastocytoses AP‐HP CEREMAST Paris France
- Service d'Hématologie Hôpital Necker AP‐HP Université Paris‐Sorbonne Paris France
| | - D. Canioni
- Centre National de Référence des Mastocytoses AP‐HP CEREMAST Paris France
- Service d'Anatomopathologie Hôpital Necker AP‐HP Université Paris‐Sorbonne Paris France
| | - S. Barete
- Unité Fonctionnelle de Dermatologie Groupe Hospitalier Pitié‐Salpêtrière, AP‐HP UPMC Université Paris 06 Sorbonne Université Paris France
- Centre National de Référence des Mastocytoses AP‐HP CEREMAST Paris France
| | | |
Collapse
|